Loading
Asst. Prof. Dr. Nisana Namwat

Asst. Prof. Dr. Nisana Namwat

Department of Biochemistry,
Faculty of Medicine,
Khon Kaen University
24559522200: H-INDEX 36
57195448675: H-INDEX 36
8509126700: H-INDEX 29

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. Tepsiri, N.N.
Wilairat, P.
Figgitt, D.P.
1994
2. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma Boonla, C
Wongkham, S
Sheehan, JK
Wongkham, C
Bhudhisawasdi, V
Tepsiri, N
Pairojkul, C
2003
3. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines Tepsiri, N
Chaturat, L
Sripa, B
Namwat, W
Wongkham, S
Bhudhisawasdi, V
Tassaneeyakul, W
2005
4. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. W Loilome
P Yongvanit
C Wongkham
N Tepsiri
B Sripa
P Sithithaworn
S Hanai
M Miwa
2006
5. Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines Nisana N. Tepsiri
Watcharin Loilome
Piyawan Amimanan
Patcharee Jearanaikoon
Wichittra Tassaneeyakul
2006
6. Plasma 8-isoprostane: a new biomarker in opisthorchiasis-associated cholangiocarcinoma Puangrat Yongvanit
Somkid Dechakhamphu
Somchai Pinlaor
Nisana N. Tepsiri
Watcharin Loilome
Narong Khantekaew
Paiboon Sithithaworn
2006
7. Prkar1a gene overexpression in liver tissue with cholangiocarcinoma Watcharin Loilome
Anucha Puapairoj
Nisana N. Tepsiri
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2006
8. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines Nisana Namwat
Banchob Sripa
Watcharin Loilome
Vajarabhongsa Bhudisawadi
Wichittra Tassaneeyakul
2007
9. Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion Peti Thuwajit
Watinee Chawengrattanachot
Chanitra Thuwajit
Banchob Sripa
Felicity E. B. May
Bruce R. Westley
Nisana N. Tepsiri
Anucha Paupairoj
Siri Chau-in
2007
10. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Nisana Namwat
Piyawan Amimanan
Watcharin Loilome
Patcharee Jearanaikoon
Banchob Sripa
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2008
11. Over-expression of PRKAR1A in hepatic progenitor cells during cholangiocarcinogenesis induced by liver fluke (Opisthorchis, viverrini) P. Yonavanit
N. Namwat
W. Loilome
R. Thanan
E. Phanomsri
C. Pairojkul
2008
12. Comparison of Antigen Retrieval Techniques in Immunohistochemistry Em-orn Phanomsri
Nisana Namwat
Sakda Waraasawapati
Roongpet Tangrassameeprasert
Supinda Koonmee
2009
13. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Chariya Hahnvajanawong
Wongwarut Boonyanugomol
Tapanawan Nasomyon
Watcharin Loilome
Nisana Namwat
Natthinee Anantachoke
Wichittra Tassaneeyakul
Banchob Sripa
Wises Namwat
Vichai Reutrakul
2010
14. Comparative study for the detection of C4d in paraffin-embedded renal allograft biopsies by immunohistochemical techniques Phanomsri, EO
Namwat, N
Tangrassameeprasert, R
Charnteeraprawat, C
Paupiroj, A
2010
15. Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation Hasaya Dokduang
Nisana Namwat
Apinya Jusakul
Vajarabhongsa Bhudisawadi
Watcharin Loilome
Puangrat Yongvanit
Banchob Sripa
Wichittra Tassaneeyakul
2010
16. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Techasen, A
Loilome, W
Namwat, N
Takahashi, E
Sugihara, E
Puapairoj, A
Miwa, M
Saya, H
Yongvanit, P
2010
17. Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines Chariya Hahnvajanawong
Vajarabhongsa Bhudisawadi
Nisana Namwat
Banchob Sripa
Wichittra Tassaneeyakul
2011
18. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011
19. Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines Chariya Hahnvajanawong
Supaluk Ketnimit
Wongwarut Boonyanugomol
Kovit Pattanapanyasat
Yaovalux Chamgramol
Banchob Sripa
Nisana Namwat
Khosit Pinmai
Wichittra Tassaneeyakul
Vichai Reutakul
2011
20. Mechanisms of oxysterol-induced carcinogenesis Jusakul, A
Yongvanit, P
Loilome, W
Namwat, N
Kuver, R
2011
21. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. Loilome, W.
Juntana, S.
Namwat, N.
Bhudhisawasdi, V.
Puapairoj, A.
Sripa, B.
Miwa, M.
Saya, H.
Yongvanit, P.
2011
22. Anti-inflammatory agents suppress the prostaglandin e2 production and migration ability of Cholangiocarcinoma cell lines Jurairat Jongthawin
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
2012
23. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Hasaya Dokduang
Jurairat Jongthawin
Puangrat Yongvanit
2012
24. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Loilome, W
Wechagama, P
Namwat, N
Jusakul, A
Sripa, B
Miwa, M
Kuver, R
Yongvanit, P
2012
25. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma N. Namwat
P. Chusorn
W. Loilome
A. Techasen
J. Puetkasichonpasutha
C. Pairojkul
N. Khuntikeo
P. Yongvanit
2012
26. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. Yongvanit, P.
Phanomsri, E.
Namwat, N.
Kampan, J.
Tassaneeyakul, W.
Loilome, W.
Puapairoj, A.
Khuntikeo, N.
2012
27. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma Apinya Jusakul
Narong Khuntikeo
W. Geoffrey Haigh
Rahul Kuver
George N. Ioannou
Watcharin Loilome
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Ake Pugkhem
Chawalit Pairojkul
Puangrat Yongvanit
2012
28. Identification of pathogenic cholesterol oxidation products in hepatic tissue and bile of cholangiocarcinoma patients A. Jusakul
W. G. Haigh
C. Savard
W. Loilome
N. Namwat
N. Khuntikeo
C. Pairojkul
S. Pinlaor
R. Kuver
P. Yongvanit
2012
29. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. Loilome, W.
Namwat, N.
Techasen, A.
Puapairoj, A.
Pinitsoontorn, C.
Yongvanit, P.
2012
30. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Yongvanit, P
Thanan, R
Pinlaor, S
Sithithaworn, P
Loilome, W
Namwat, N
Techasen, A
Dechakhamphu, S
2012
31. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Jusakul, A.
Loilome, W.
Namwat, N.
Dechakhamphu, S.
Sukontawarin, P.
Pinlaor, S.
Lee, S.P.
Yongvanit, P.
2012
32. Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma Nisana Namwat
Watcharin Loilome
Puangrat Yongvanit
Thailand Khon Kaen University
2012
33. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Techasen, A
Loilome, W
Namwat, N
Duenngai, K
Cha'on, U
Thanan, R
Sithithaworn, P
Miwa, M
Yongvanit, P
2012
34. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. Chariya Hahnvajanawong
Jariya Chaiyagool
Wunchana Seubwai
Vajarabhongsa Bhudhisawasdi
Nisana Namwat
Narong Khuntikeo
Banchob Sripa
Ake Pugkhem
Wichittra Tassaneeyakul
2012
35. Plama MicroRNAs: a Biomarker for Cancer Diagnosis Runglawan Silakit
Nisana Namwat
2012
36. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Watcharin Loilome
Sasithorn Yooyuen
Nisana Namwat
Paiboon Sithithaworn
Anucha Puapairoj
Junko Kano
Masayuki Noguchi
Masanao Miwa
Puangrat Yongvanit
2012
37. Suppression of PRKAR1A Expression Enhances Antiproliferative and Apoptotic Effects of Protein Kinase Inhibitors and Chemotherapeutic Drugs on Cholangiocarcinoma Cells Loilome, W
Juntana, S
Pinitsoontorn, C
Namwat, N
Tassaneeyakul, W
Yongvanit, P
2012
38. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Techasen, A.
Namwat, N.
Loilome, W.
Bungkanjana, P.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2012
39. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. Jusakul, A.
Loilome, W.
Namwat, N.
Techasen, A.
Ioannou, G.N.
Yongvanit, P.
2013
40. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine. Amornrat Juasook
Thidarut Boonmars
Zhiliang Wu
Watcharin Loilome
Kulathida Veteewuthacharn
Nissana Namwat
Pakkayanee Sudsarn
Orasa Wonkchalee
Pranee Sriraj
Ratchadawan Aukkanimart
2013
41. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong, S.
Dokduang, H.
Techasen, A.
Namwat, N.
Yongvanit, P.
Bhudhisawasdi, V.
Puapairoj, A.
Loilome, W.
2013
42. Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model Hasaya Dokduang
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Chawalit Pairojkul
Narong Khuntikeo
Yoshinori Murakami
Puangrat Yongvanit
2013
43. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Chusorn, P.
Namwat, N.
Loilome, W.
Techasen, A.
Pairojkul, C.
Khuntikeo, N.
Talabnin, C.
Chan-On, W.
Yongvanit, P.
2013
44. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Wassana Jamnongkan
Anchalee Techasen
Raynoo Thanan
Kunyarat Duenngai
Paiboon Sithithaworn
Eimorn Mairiang
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Puangrat Yongvanit
2013
45. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Dokduang, H
Juntana, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Riggins, GJ
Loilome, W
2013
46. The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma Jurairat Jongthawin
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Chavalit Pairojkul
Narong Khuntikeo
Nisana Namwat
2013
47. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Loilome, W.
Bungkanjana, P.
Techasen, A.
Namwat, N.
Yongvanit, P.
Puapairoj, A.
Khuntikeo, N.
2014
48. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014
49. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. Duangkumpha, K.
Techasen, A.
Loilome, W.
Namwat, N.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2014
50. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Porncheera Chusorn
Anchalee Techasen
Thidarut Boonmars
Narong Khuntikeo
Nittaya Chamadol
Chawalit Pairojkul
Nisana Namwat
2014
51. Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression Yingpinyapat Kittirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
52. Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
53. Gene Silencing of Translationally Controlled Tumor Protein (TCTP) Nattaporn Phanthaphol
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
54. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014
55. Increased EphB2 expression predicts cholangiocarcinoma metastasis. Walaiporn Khansaard
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Watcharin Loilome
2014
56. Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development H. Dokduang
W. Loilome
N. Namwat
C. Pairojkul
M. Sakurai-Yageta
Y. Murakami
P. Yongvanit
2014
57. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2014
58. Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways in a cholangiocarcinogenesis model Supak Yothaisong
Malinee Thanee
Nisana Namwat
Puangrat Yongvanit
Thidarut Boonmars
Anucha Puapairoj
Watcharin Loilome
2014
59. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. Jongthawin, J.
Chusorn, P.
Techasen, A.
Loilome, W.
Boonmars, T.
Thanan, R.
Puapairoj, A.
Khuntikeo, N.
Tassaneeyakul, W.
Yongvanit, P.
Namwat, N.
2014
60. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Dokduang, H
Techasen, A
Namwat, N
Khuntikeo, N
Pairojkul, C
Murakami, Y
Loilome, W
Yongvanit, P
2014
61. Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment W. Loilome
H. Dokduang
S. Yothaisong
P. Bungkanjana
S. Juntana
A. Techasen
N. Namwat
P. Yongvanit
N. Khuntikeo
A. Puapairoj
2014
62. TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
B. Tean Teh
I. Lee
P. Yongvanit
2014
63. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Kassaporn Duangkumpha
Anucha Puapairoj
Hideyuki Saya
Puangrat Yongvanit
2014
64. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine Worasith, C
Kamamia, C
Yakovleva, A
Duenngai, K
Wangboon, C
Sithithaworn, J
Watwiengkam, N
Namwat, N
Techasen, A
Loilome, W
Yongvanit, P
Loukas, A
Sithithaworn, P
Bethony, JM
2015
65. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. Thongchot, S.
Loilome, W.
Yongvanit, P.
Dokduang, H.
Thanan, R.
Techasen, A.
Namwat, N.
2015
66. Cohort profile: cholangiocarcinoma screening and care program (CASCAP) Khuntikeo, N.
Chamadol, N.
Yongvanit, P.
Loilome, W.
Namwat, N.
Sithithaworn, P.
Andrews, R.H.
Petney, T.N.
Promthet, S.S.
Thinkhamrop, K.
Tawarungruang, C.
Thinkhamrop, B.
2015
67. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wareeporn Wattanawongdon
Chariya Hahnvajanawong
Nisana Namwat
Sirimas Kanchanawat
Thidarut Boonmars
Patcharee Jearanaikoon
Chanwit Leelayuwat
Anchalee Techasen
Wunchana Seubwai
2015
68. Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis Thanee, M
Loilome, W
Techasen, A
Namwat, N
Boonmars, T
Pairojkul, C
Yongvanit, P
2015
69. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Eiji Sugihara
Shogo Okazaki
Shinya Abe
Shiho Ueda
Takashi Masuko
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Chawalit Pairojkul
Hideyuki Saya
Puangrat Yongvanit
2016
70. Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand Narong Khuntikeo
Paiboon Sithithaworn
Watcharin Loilom
Nisana Namwat
Puangrat Yongvanit
Bandit Thinkhamrop
Nadda Kiatsopit
Ross H. Andrews
Trevor N. Petney
2016
71. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma Sudsarn, P
Boonmars, T
Ruangjirachuporn, W
Namwat, N
Loilome, W
Sriraj, P
Aukkanimart, R
Nadchanan, W
Jiraporn, S
2016
72. Potential of selenium compounds as new anticancer agents for cholangiocarcinoma Dai, X
Thongchot, S
Dokduang, H
Loilome, W
Khuntikeo, N
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Techasen, A
Namwat, N
2016
73. Xanthohumol inhibits STAT3 activation pathway leaDing to growth suppression and apoptosis induction in human cholangiocarcinoma cells Hasaya Dokduang
Puangrat Yongvanit
Nisana Namwat
Chawalit Pairojkul
Sakkarn Sangkhamanon
Mika Sakurai Yageta
Yoshinori Murakami
Watcharin Loilome
2016
74. Carcinogenic liver fluke and others contaminated in pickled fish of northeastern Thailand Aukkanimart, R
Boonmars, T
Sriraj, P
Sripan, P
Songsri, J
Ratanasuwan, P
Laummaunwai, P
Suwanantrai, A
Aunpromma, S
Khueangchaingkhwang, S
Pumhirunroj, B
Artchayasawat, A
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Boonjaraspinyo, S
2017
75. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand Senggunprai, L.
Namwat, N.
Kongpetch, S.
Chamgramol, Y.
Loilome, W.
Khansaard, W.
Jusakul, A.
Prawan, A.
Pairojkul, C.
Yongvanit, P.
Kukongviriyapan, V.
2017
76. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Loilome, W
Kadsanit, S
Muisook, K
Yongvanit, P
Namwat, N
Techasen, A
Puapairoj, A
Khuntikeo, N
Phonjit, P
2017
77. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Supak Yothaisong
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Promsuk Jutabha
Naohiko Anzai
Wichittra Tassaneeyakul
Panot Tangsucharit
Watcharin Loilome
2017
78. Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Yothaisong, S.
Dokduang, H.
Namwat, N.
Yongvanit, P.
Loilome, W.
2017
79. Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017
80. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem Hughes, T
O'Connor, T
Techasen, A
Namwat, N
Loilome, W
Andrews, RH
Khuntikeo, N
Yongvanit, P
Sithithaworn, P
Taylor-Robinson, SD
2017
81. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Armartmuntree, N
Murata, M
Techasen, A
Yongvanit, P
Loilome, W
Namwat, N
Pairojkul, C
Sakonsinsiri, C
Pinlaor, S
Thanan, R
2017
82. Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish Boonmars, T.
Songsri, J.
Aukkanimart, R.
Sriraj, P.
Rattanasuwan, P.
Suwannatrai, A.
Aunpromma, S.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
Boonjaraspinyo, S.
2017
83. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Manida Suksawat
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Supinda Koonmee
Watcharin Loilome
2017
84. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Techasen, A.
Thongchot, S.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2017
85. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool Jamnongkan, W
Thanan, R
Techasen, A
Namwat, N
Loilome, W
Intarawichian, P
Titapun, A
Yongvanit, P
2017
86. Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool Wassana Jamnongkan
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Piyapharom Intarawichian
Attapol Titapun
Puangrat Yongvanit
2017
87. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. Loilome, W.
Yongvanit, P.
Thongchot, S.
Namwat, N.
Sithithaworn, P.
Boonmars, T.
Koonmee, S.
Titapun, A.
Khuntikeo, N.
Chamadol, N.
Techasen, A.
2017
88. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Rayno Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
Anchalee Techasen
2018
89. CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Nisana Namwat
Attapon Titapun
Narong Khuntikeo
Shogo Okazaki
Eiji Sugihara
Hideyuki Saya
Puangrat Yongvanit
2018
90. Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma Chayanit Piyawajanusorn
Watcharin Loilome
Yingpinyapat Kittirat
Suyanee Thongchot
Nisana Namwat
2018
91. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway Thongchot, S
Vidoni, C
Ferraresi, A
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018
92. Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis Anchalee Techasen
Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
2018
93. Erratum to “Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells” (Cancer Letters (2018) 430 (160–171), (S0304383518303641) (10.1016/j.canlet.2018.05.031)) Thongchot, S.
Loilome,
Yongvanit, P.
2018
94. Erratum to "Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells" [Cancer Letters 430C (2018) 160-171]. Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018
95. Expressions of FOXAs in relation with good prognosis of cholangiocarcinoma Waleeporn Kaewlert
Napat Armartmuntree
Nisana Namwat
Kanlayanee Sawanyawisuth
Chadamas Sakonsinsiri
Raynoo Thanan
2018
96. Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development Sasikamon Korphai
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
2018
97. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy Suksawat, M
Techasen, A
Namwat, N
Boonsong, T
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Loilome, W
2018
98. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018
99. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018
100. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Dokduang, H.
Yothaisong, S.
Techasen, A.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Loilome,
2018
101. Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018
102. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018
103. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. Thongchot, S.
Loilome,
Techasen, A.
Ungarreevittaya, P.
Khuntikeo, N.
Yongvanit, P.
2018
104. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Daya, M
Loilome, W
Techasen, A
Thanee, M
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Namwat, N
2018
105. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Armartmuntree, N.
Techasen, A.
Yongvanit, P.
Loilome, W.
Pairojkul, C.
Sakonsinsiri, C.
Pinlaor, S.
Thanan, R.
2018
106. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018
107. Resveratrol interrupts the pro -invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells (vol 430C, pg 160, 2018) Suyanee Thongchot
Alessandra Ferraresi
Chiara Vidoni
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018
108. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine Techasen, A.
Thongchot, S.
Loilome, W.
Thanan, R.
Yongvanit, P.
Titapun, A.
Khuntikeo, N.
Namwat, N.
2018
109. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018
110. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018
111. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018
112. The importance of aromatase, an estrogen biosynthesis enzyme, in cholangiocarcinoma progression Raynoo Thanan
Waleeporn Kaewlert
Napat Armartmuntree
Chadamas Sakonsinsiri
Nisana Namwat
Kanlayanee Sawanyawisuth
Piti Ungarreevittaya
2018
113. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma Waleeporn Kaewlert
Chadamas Sakonsinsiri
Nisana Namwat
Kanlayanee Sawanyawisuth
Piti Ungarreevittaya
Narong Khuntikeo
Napat Armartmuntree
Raynoo Thanan
2018
114. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway Sasikamon Khophai
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Poramate Klanrit
Attapol Titapun
Apiwat Jarearnrat
Prakasit Sa-Ngiamwibool
Watcharin Loilome
2018
115. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. Duenngai, K.
Kiatsopit, N.
Kopolrat, K.
Techasen, A.
Sithithaworn, J.
Khuntikeo, N.
Loilome,
Yongvanit, P.
Sithithaworn, P.
2019
116. Detection of the G1138A mutation in the FGFR3 gene for the diagnosis of achondroplasia by allele-specific polymerase chain reaction Imtawil, K.J.
Loilome, W.
Tangrassameeprasert, R.
Wichajarn, K.
2019
117. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019
118. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Promraksa, B
Phetcharaburanin, J
Namwat, N
Techasen, A
Boonsiri, P
Loilome, W
2019
119. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Klanrit,
Phetcharaburanin, J.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Loilome,
2019
120. PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. Piyawajanusorn, C
Kittirat, Y
Sa-Ngiamwibool, P
Titapun, A
Loilome, W
Namwat, N
2019
121. PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells Chayanit Piyawajanusorn
Yingpinyapat Kittirat
Prakasit Sa-Ngiamwibool
Attapol Titapun
Watcharin Loilome
Nisana Namwat
2019
122. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress Armartmuntree, N.
Techasen, A.
Sakonsinsiri, C.
Pinlaor, S.
Ungarreevittaya, P.
Khuntikeo, N.
Thanan, R.
2019
123. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019
124. 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. Phetcharaburanin, J
Deewai, S
Kulthawatsiri, T
Moolpia, K
Suksawat, M
Promraksa, B
Klanrit, P
Namwat, N
Loilome, W
Poopasit, K
Katekaew, S
Phetcharaburanin, P
2020
125. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients Narong Khuntikeo
Supinda Koonmee
Prakasit Sa-Ngiamwibool
Nittaya Chamadol
Vallop Laopaiboon
Attapol Titapun
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Ross H. Andrews
Trevor N. Petney
Kavin Thinkhamrop
Nathaphop Chaichaya
Chaiwat Tawarungruang
Jaruwan Thuanman
Bandit Thinkhamrop
2020
126. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Loilome, W
2020
127. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Taron, W
Jamnongkan, W
Techasen, A
Phetcharaburanin, J
Namwat, N
Sithithaworn, P
Khuntikeo, N
Mukdasai, S
Sayasone, S
Loilome, W
Ngeontae, W
2020
128. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Thongchot, S.
Thanee, M.
Loilome, W.
Techasen, A.
Titapun, A.
Yongvanit, P.
Namwat, N.
2020
129. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. Thongchot, S
Thanee, M
Loilome, W
Techasen, A
Boonmars, T
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Isidoro, C
Namwat, N
2020
130. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients. Puetkasichonpasutha, J.
Namwat, N.
Titapun, A.
Suthiphongchai, T.
2020
131. H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination Jutarop Phetcharaburanin
Suthicha Deewai
Thanaporn Kulthawatsiri
Komkid Moolpia
Manida Suksawat
Bundit Promraksa
Poramate Klanrit
Nisana Namwat
Watcharin Loilome
Kitisak Poopasit
Somporn Katekaew
Penprapa Phetcharaburanin
2020
132. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines Dokduang, H.
Promraksa, B.
Thanee, M.
Phetcharaburanin, J.
Namwat, N.
Titapun, A.
Khuntikeo, N.
Klanrit, P.
Loilome, W.
2020
133. LIVER FLUKE-INFECTED CYPRINOID FISH IN NORTHEASTERN THAILAND (2016-2017) Pumhirunroj, B.
Aukkanimart, R.
Boonmars, T.
Sriraj, P.
Boueroy, P.
Artchayasawat, A.
Songsri, J.
Sripan, P.
Ratanasuwan, P.
Laummaunwai, P.
Khueangchaingkhwang, S.
Aunpromma, S.
Eamudomkarn, C.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
2020
134. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. Thanee, M.
Phetcharaburanin, J.
Klanrit, P.
Khuntikeo, N.
Titapun, A.
Saya, H.
Loilome, W.
2020
135. 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination Phetcharaburanin, J.
Moolpia, K.
Suksawat, M.
Promraksa, B.
Klanrit, P.
Namwat, N.
Loilome, W.
Poopasit, K.
Katekaew, S.
Phetcharaburanin, P.
2020
136. A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples Wichit Taron
Wassana Jamnongkan
Jutarop Phetcharaburanin
Poramate Klanrit
Nisana Namwat
Anchalee Techasen
Paiboon Sithithaworn
Narong Khuntikeo
Thidarut Boonmars
Watcharin Loilome
Wittaya Ngeontae
2021
137. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway Sutthiwan Janthamala
Apinya Jusakul
Sarinya Kongpetch
Phongsaran Kimawaha
Poramate Klanrit
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
2021
138. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits Phuc N. Ho
Poramate Klanrit
Yupa Hanboonsong
Umaporn Yordpratum
Manida Suksawat
Thanaporn Kulthawatsiri
Anyarin Jirahiranpat
Suthicha Deewai
Panya Mackawan
Rasana W. Sermswan
Nisana Namwat
Watcharin Loilome
Tueanjit Khampitak
Arporn Wangwiwatsin
Jutarop Phetcharaburanin
2021
139. Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse Suyanee Thongchot
Chiara Vidoni
Alessandra Ferraresi
Watcharin Loilome
Narong Khuntikeo
Sakkarn Sangkhamanon
Attapol Titapun
Ciro Isidoro
Nisana Namwat
2021
140. Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse Thongchot, S.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Namwat, N.
2021
141. CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression Thanee, M
Dokduang, H
Kittirat, Y
Phetcharaburanin, J
Klanrit, P
Titapun, A
Namwat, N
Khuntikeo, N
Wangwiwatsin, A
Saya, H
Loilome, W
2021
142. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma Preawwalee Wintachai
Jing Quan Lim
Anchalee Techasen
Worachart Lert-Itthiporn
Sarinya Kongpetch
Watcharin Loilome
Jarin Chindaprasirt
Attapol Titapun
Nisana Namwat
Narong Khuntikeo
Apinya Jusakul
2021
143. Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma Wintachai, P.
Techasen, A.
Lert-Itthiporn, W.
Kongpetch, S.
Loilome, W.
Titapun, A.
Namwat, N.
Khuntikeo, N.
Jusakul, A.
2021
144. Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma Padthaisong, S
Phetcharaburanin, J
Klanrit, P
Li, JV
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Wangwiwatsin, A
Mahalapbutr, P
Loilome, W
2021
145. Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction Yingpinyapat Kittirat
Jutarop Phetcharaburanin
Bundit Promraksa
Thanaporn Kulthawatsiri
Arporn Wangwiwatsin
Poramate Klanrit
Sakkarn Sangkhamanon
Apiwat Jarearnrat
Suyanee Thongchot
Panupong Mahalapbutr
Watcharin Loilome
Hideyuki Saya
Nisana Namwat
2021
146. Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment Promraksa, B.
Katrun, P.
Phetcharaburanin, J.
Namwat, N.
Techasen, A.
Loilome, W.
2021
147. Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. Prommajun, P
Phetcharaburanin, J
Namwat, N
Klanrit, P
Sa-Ngiamwibool, P
Thanee, M
Dokduang, H
Kittirat, Y
Li, JV
Loilome, W
2021
148. Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma Phetcharaburanin, J.
Namwat, N.
Klanrit, P.
Thanee, M.
Dokduang, H.
Loilome, W.
2021
149. Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples Wichit Taron
Kittirat Phooplub
Sasina Sanchimplee
Kanitpong Piyanamvanich
Wassana Jamnongkan
Anchalee Techasen
Jutarop Phetcharaburanin
Poramate Klanrit
Nisana Namwat
Narong Khuntikeo
Thidarut Boonmars
Paiboon Sithithaworn
Sirirat Ouiganon
Proespichaya Kanatharana
Panote Thavarungkul
Chittanon Buranachai
Watcharin Loilome
Wittaya Ngeontae
2021
150. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models Thanee, M
Padthaisong, S
Suksawat, M
Dokduang, H
Phetcharaburanin, J
Klanrit, P
Titapun, A
Namwat, N
Wangwiwatsin, A
Sa-Ngiamwibool, P
Khuntikeo, N
Saya, H
Loilome, W
2021
151. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. Jittima Tomacha
Hasaya Dokduang
Sureerat Padthaisong
Nisana Namwat
Poramate Klanrit
Jutarop Phetcharaburanin
Arporn Wangwiwatsin
Tueanjit Khampitak
Supinda Koonmee
Attapol Titapun
Apiwat Jarearnrat
Narong Khuntikeo
Watcharin Loilome
2021
152. Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker Puetkasichonpasutha, J.
Namwat, N.
Titapun, A.
Suthiphongchai, T.
2022
153. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles Sitthirak, S
Suksawat, M
Phetcharaburanin, J
Wangwiwatsin, A
Klanrit, P
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sangkhamanon, S
Loilome, W
2022
154. Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma Kittirat, Y
Suksawat, M
Thongchot, S
Padthaisong, S
Phetcharaburanin, J
Wangwiwatsin, A
Klanrit, P
Sangkhamanon, S
Titapun, A
Loilome, W
Saya, H
Namwat, N
2022
155. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma Suksawat, M
Phetcharaburanin, J
Klanrit, P
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Vilayhong, V
Sa-Ngiamwibool, P
Techasen, A
Wangwiwatsin, A
Mahalapbutr, P
Li, JV
Loilome, W
2022
156. Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. Worasith, C
Sithithaworn, J
Wongphutorn, P
Homwong, C
Khongsukwiwat, K
Techasen, A
Kopolrat, KY
Loilome, W
Namwat, N
Thinkamrop, B
Tawarungruang, C
Titapun, A
Laha, T
Andrews, RH
Taylor-Robinson, SD
Sithithaworn, P
2023
157. H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. Treeriya, R
Ho, PN
Titapun, A
Klanrit, P
Suksawat, M
Kulthawatsiri, T
Sirirattanakul, S
Loilome, W
Namwat, N
Wangwiwatsin, A
Chamadol, N
Khuntikeo, N
Phetcharaburanin, J
2023
158. Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. Kulthawatsiri, T
Kittirat, Y
Phetcharaburanin, J
Tomacha, J
Promraksa, B
Wangwiwatsin, A
Klanrit, P
Titapun, A
Loilome, W
Namwat, N
2023
159. Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. Thongchot, S
Ferraresi, A
Vidoni, C
Salwa, A
Vallino, L
Kittirat, Y
Loilome, W
Namwat, N
Isidoro, C
2023
160. The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility. Loilome, W
Namwat, N
Jusakul, A
Techasen, A
Klanrit, P
Phetcharaburanin, J
Wangwiwatsin, A
2023
161. The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. Phukhum, P.
Phetcharaburanin, J.
Chaleekarn, K.
Kittirat, Y.
Kulthawatsiri, T.
Namwat, N.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Wangwiwatsin, A.
Khampitak, T.
Suksawat, M.
Klanrit, P.
2023
162. Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and . Wangwiwatsin, A
Kulwong, S
Phetcharaburanin, J
Namwat, N
Klanrit, P
Loilome, W
Maleewong, W
Reid, AJ
2023
163. Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia Wangwiwatsin, A.
Kulwong, S.
Phetcharaburanin, J.
Namwat, N.
Klanrit, P.
Loilome, W.
Maleewong, W.
Reid, A.J.
2023
164. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Islam, K
Balasubramanian, B
Venkatraman, S
Thummarati, P
Tunganuntarat, J
Phueakphud, N
Kanjanasirirat, P
Khumpanied, T
Kongpracha, P
Kittirat, Y
Tohtong, R
Janvilisri, T
Wongtrakoongate, P
Borwornpinyo, S
Namwat, N
Suthiphongchai, T
2023
165. Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines Janthamala, S
Promraksa, B
Thanee, M
Duenngai, K
Jusakul, A
Kongpetch, S
Kraiklang, R
Thanee, K
Pinlaor, P
Namwat, N
Saya, H
Techasen, A
2024
166. Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells. Islam, K
Balasubramanian, B
Venkatraman, S
Thummarati, P
Tunganuntarat, J
Phueakphud, N
Kanjanasirirat, P
Khumpanied, T
Kongpracha, P
Kittirat, Y
Tohtong, R
Janvilisri, T
Wongtrakoongate, P
Borwornpinyo, S
Namwat, N
Suthiphongchai, T
2024
167. Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. Thanasukarn, V
Srisuk, T
Luvira, V
Tipwaratorn, T
Jareanrat, A
Rattanarak, K
Kraphunpongsakul, K
Khuntikeo, N
Chindaprasirt, J
Sanlung, T
Chamadol, N
Koonmee, S
Sa-Ngiamwibool, P
Klanrit, P
Wangwiwatsin, A
Namwat, N
Loilome, W
Muangritdech, N
Prajumwongs, P
Watanabe, N
Ebata, T
Titapun, A
2024
168. Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. Win, ZZ
Dokduang, H
Kulwong, S
Loilome, W
Namwat, N
Phetcharaburanin, J
Wongsurawat, T
Jenjaroenpun, P
Klanrit, P
Wangwiwatsin, A
2025
169. Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. Dokduang, H
Jarernrat, A
Titapun, A
Sitthirak, S
Padthaisong, S
Kittirat, Y
Sangkamanon, S
Sa-Ngiamwibool, P
Wangwiwatsin, A
Klanrit, P
Namwat, N
Jusakul, A
Murakami, Y
Loilome, W
2025
170. Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (). Dokduang, H
Katenak, A
Kittirat, Y
Tomacha, J
Promraksa, B
Taing, L
Na Nakorn, S
Klanrit, P
Namwat, N
Titapun, A
Loilome, W
2025
171. Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. Taron, W
Jamnongkan, W
Kamjanlard, C
Phetcharaburanin, J
Wangwiwatsin, A
Klanrit, P
Namwat, N
Techasen, A
Titapun, A
Boonmars, T
Laummaunwai, P
Sithithaworn, P
Ngeontae, W
Loilome, W
2025
172. Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. Thanasukarn, V
Prajumwongs, P
Muangritdech, N
Loilome, W
Namwat, N
Klanrit, P
Wangwiwatsin, A
Charoenlappanit, S
Jaresitthikunchai, J
Roytrakul, S
Titapun, A
2025
173. Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. Jaidee, R
Jusakul, A
Pocasap, P
Kukongviriyapan, V
Senggunprai, L
Prawan, A
Loilome, W
Titapun, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Namwat, N
Chamgramol, Y
Thanee, M
Wichian, P
Hong, JH
Guan, P
Heng, HL
Pairojkul, C
Teh, BT
Kongpetch, S
2025
174. Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. Prajumwongs, P
Titapun, A
Thanasukarn, V
Jareanrat, A
Khuntikeo, N
Namwat, N
Klanrit, P
Wangwiwatsin, A
Chindaprasirt, J
Koonmee, S
Sa-Ngiamwibool, P
Muangritdech, N
Roytrakul, S
Loilome, W
2025
175. Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection. Kopolrat, KY
Worasith, C
Wongphutorn, P
Techasen, A
Eamudomkarn, C
Sithithaworn, J
Loilome, W
Namwat, N
Titapun, A
Tawarungruang, C
Thinkhamrop, B
Futrakul, S
Taylor-Robinson, SD
Haswell, MR
Khuntikeo, N
Crellen, T
Sithithaworn, P
2025
176. Metabolomic analysis of bioactive compounds in dill ( L.) extracts. Thanuma, J
Phetcharaburanin, J
Dokduang, H
Loilome, W
Klanrit, P
Wangwiwatsin, A
Namwat, N
2025
177. Mitochondrial genomic alterations in cholangiocarcinoma cell lines. Faipan, A
Sitthirak, S
Wangwiwatsin, A
Namwat, N
Klanrit, P
Titapun, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Boulter, L
Dokduang, H
Loilome, W
2025
178. Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. Thongyoo, P
Chindaprasirt, J
Aphivatanasiri, C
Intarawichian, P
Kunprom, W
Kongpetch, S
Techasen, A
Loilome, W
Namwat, N
Titapun, A
Jusakul, A
2025
179. Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. Sitthirak, S
Roytrakul, S
Wangwiwatsin, A
Namwat, N
Klanrit, P
Dokduang, H
Sa-Ngiamwibool, P
Titapan, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Boulter, L
Loilome, W
2025
180. The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. Wangwiwatsin, A
Kulwong, S
Phuyao, C
Titapun, A
Loilome, W
Klanrit, P
Namwat, N
Sithithaworn, P
Doyle, SR
Berriman, M
Crellen, T
,
,
,
,
2025
181. Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. Sitthirak, S
Wangwiwatsin, A
Jusakul, A
Namwat, N
Klanrit, P
Dokduang, H
Sa-Ngiamwibool, P
Titapun, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Teh, BT
Boulter, L
Murakami, Y
Loilome, W
2025
Count 112 126 118 10

Title Authors Year Publication name Cited count
< 2020 2021 2022 2023 2024 2025 Total
1. Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum Tepsiri, N.N.
Wilairat, P.
Figgitt, D.P.
1994 Journal of Medicinal Chemistry
10 (37), pp. 1486-1494
2. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma Boonla, C.
Wongkham, S.
Wongkham, C.
Bhudhisawasdi, V.
Tepsiri, N.N.
Pairojkul, C.
2003 Cancer
7 (98), pp. 1438-1443
3. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines Tepsiri, N.N.
Chaturat, L.
Sripa, B.
Namwat, W.
Wongkham, S.
Bhudhisawasdi, V.
Tassaneeyakul, W.
2005 World Journal of Gastroenterology
18 (11), pp. 2748-2753
4. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model Loilome, W.
Yongvanit, P.
Wongkham, C.
Tepsiri, N.N.
Sripa, B.
Sithithaworn, P.
Miwa, M.
2006 Molecular Carcinogenesis
5 (45), pp. 279-287
5. Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion Thuwajit, P.
Chawengrattanachot, W.
Thuwajit, C.
Sripa, B.
Tepsiri, N.N.
Paupairoj, A.
Chau-In, S.
2007 Hepatology Research
4 (37), pp. 295-304
6. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Namwat, N.
Amimanan, P.
Loilome, W.
Jearanaikoon, P.
Sripa, B.
Bhudhisawasdi, V.
Tassaneeyakul, W.
2008 Chemotherapy
5 (54), pp. 343-351
7. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Hahnvajanawong, C.
Boonyanugomol, W.
Nasomyon, T.
Loilome, W.
Namwat, N.
Anantachoke, N.
Tassaneeyakul, W.
Sripa, B.
Namwat, W.
Reutrakul, V.
2010 World Journal of Gastroenterology
18 (16), pp. 2235-2243
8. Comparative study for the detection of C4d in paraffin-embedded renal allograft biopsies by immunohistochemical techniques Phanomsri, E.O.
Namwat, N.
Tangrassameeprasert, R.
Paupiroj, A.
2010 Journal of the Medical Association of Thailand
SUPPL 3 (93), pp. S61-S68
9. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Techasen, A.
Loilome, W.
Namwat, N.
Takahashi, E.
Puapairoj, A.
Miwa, M.
Saya, H.
Yongvanit, P.
2010 Cancer Science
3 (101), pp. 658-665
10. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases Namwat, N.
Puetkasichonpasutha, J.
Loilome, W.
Yongvanit, P.
Techasen, A.
Puapairoj, A.
Sripa, B.
Tassaneeyakul, W.
Khuntikeo, N.
Wongkham, S.
2011 Journal of Gastroenterology
5 (46), pp. 664-675
11. Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines Hahnvajanawong, C.
Ketnimit, S.
Boonyanugomol, W.
Chamgramol, Y.
Sripa, B.
Namwat, N.
Pinmai, K.
Tassaneeyakul, W.
Reutrakul, V.
2011 Asian Biomedicine
6 (5), pp. 775-785
12. Mechanisms of oxysterol-induced carcinogenesis Jusakul, A.
Yongvanit, P.
Loilome, W.
Namwat, N.
2011 Lipids in Health and Disease
(10), pp.
13. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma Loilome, W.
Juntana, S.
Namwat, N.
Bhudhisawasdi, V.
Puapairoj, A.
Sripa, B.
Miwa, M.
Saya, H.
Yongvanit, P.
2011 International Journal of Cancer
1 (129), pp. 34-44
14. Anti-inflammatory agents suppress the prostaglandin e2 production and migration ability of Cholangiocarcinoma cell lines Jongthawin, J.
Techasen, A.
Loilome, W.
Yongvanit, P.
Namwat, N.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 47-51
15. Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells Techasen, A.
Loilome, W.
Namwat, N.
Dokduang, H.
Jongthawin, J.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 115-118
16. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Loilome, W.
Wechagama, P.
Namwat, N.
Jusakul, A.
Sripa, B.
Miwa, M.
Yongvanit, P.
2012 Parasitology International
1 (61), pp. 136-139
17. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma Namwat, N.
Chusorn, P.
Loilome, W.
Techasen, A.
Puetkasichonpasutha, J.
Pairojkul, C.
Khuntikeo, N.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 65-69
18. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Yongvanit, P.
Phanomsri, E.
Namwat, N.
Kampan, J.
Tassaneeyakul, W.
Loilome, W.
Puapairoj, A.
Khuntikeo, N.
2012 Parasitology International
1 (61), pp. 162-166
19. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma Jusakul, A.
Khuntikeo, N.
Ioannou, G.N.
Loilome, W.
Namwat, N.
Bhudhisawasdi, V.
Pugkhem, A.
Pairojkul, C.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 77-82
20. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development Loilome, W.
Namwat, N.
Techasen, A.
Puapairoj, A.
Pinitsoontorn, C.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 59-64
21. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Yongvanit, P.
Thanan, R.
Pinlaor, S.
Sithithaworn, P.
Loilome, W.
Namwat, N.
Techasen, A.
Dechakhamphu, S.
2012 Parasitology Research
5 (110), pp. 1969-1977
22. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Jusakul, A.
Loilome, W.
Namwat, N.
Dechakhamphu, S.
Sukontawarin, P.
Pinlaor, S.
Lee, S.P.
Yongvanit, P.
2012 Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
1-2 (731), pp. 48-57
23. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Techasen, A.
Loilome, W.
Namwat, N.
Duenngai, K.
Cha'on, U.
Thanan, R.
Sithithaworn, P.
Miwa, M.
Yongvanit, P.
2012 Parasitology International
1 (61), pp. 140-144
24. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Hahnvajanawong, C.
Chaiyagool, J.
Seubwai, W.
Bhudhisawasdi, V.
Namwat, N.
Khuntikeo, N.
Sripa, B.
Pugkhem, A.
Tassaneeyakul, W.
2012 World Journal of Gastroenterology
30 (18), pp. 3955-3961
25. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Loilome, W.
Yooyuen, S.
Namwat, N.
Sithithaworn, P.
Puapairoj, A.
Kano, J.
Miwa, M.
Yongvanit, P.
2012 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (33), pp. 2289-2298
26. Suppression of PRKAR1A expression enhances antiproliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma Cells Loilome, W.
Juntana, S.
Pinitsoontorn, C.
Namwat, N.
Tassaneeyakul, W.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 143-147
27. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Techasen, A.
Namwat, N.
Loilome, W.
Bungkanjana, P.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2012 Medical Oncology
5 (29), pp. 3083-3091
28. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Jusakul, A.
Loilome, W.
Namwat, N.
Techasen, A.
Ioannou, G.N.
Yongvanit, P.
2013 Journal of Steroid Biochemistry and Molecular Biology
(138), pp. 368-375
29. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine Juasook, A.
Boonmars, T.
Loilome, W.
Veteewuthacharn, K.
Namwat, N.
Namwat, N.
Sudsarn, P.
Wonkchalee, O.
Sriraj, P.
Aukkanimart, R.
2013 Pathology and Oncology Research
1 (19), pp. 55-62
30. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Yothaisong, S.
Dokduang, H.
Techasen, A.
Namwat, N.
Yongvanit, P.
Bhudhisawasdi, V.
Puapairoj, A.
Loilome, W.
2013 Tumor Biology
6 (34), pp. 3637-3648
31. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis Chusorn, P.
Namwat, N.
Loilome, W.
Techasen, A.
Pairojkul, C.
Khuntikeo, N.
Talabnin, C.
Chan-On, W.
Yongvanit, P.
2013 Tumor Biology
3 (34), pp. 1579-1588
32. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Jamnongkan, W.
Techasen, A.
Thanan, R.
Duenngai, K.
Sithithaworn, P.
Mairiang, E.
Loilome, W.
Namwat, N.
Pairojkul, C.
Yongvanit, P.
2013 Tumor Biology
2 (34), pp. 695-704
33. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Dokduang, H.
Juntana, S.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Loilome, W.
2013 Tumor Biology
6 (34), pp. 3519-3528
34. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells Loilome, W.
Bungkanjana, P.
Techasen, A.
Namwat, N.
Yongvanit, P.
Puapairoj, A.
Khuntikeo, N.
2014 Tumor Biology
6 (35), pp. 5357-5367
35. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression Khenjanta, C.
Thanan, R.
Jusakul, A.
Techasen, A.
Jamnongkan, W.
Namwat, N.
Loilome, W.
Pairojkul, C.
Yongvanit, P.
2014 Asian Pacific Journal of Cancer Prevention
23 (15), pp. 10187-10192
36. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma Duangkumpha, K.
Techasen, A.
Loilome, W.
Namwat, N.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 9667-9676
37. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator Loilome, W.
Yongvanit, P.
Chusorn, P.
Techasen, A.
Boonmars, T.
Khuntikeo, N.
Chamadol, N.
Pairojkul, C.
Namwat, N.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
12 (21), pp. 864-872
38. High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014 Asian Pacific Journal of Cancer Prevention
14 (15), pp. 5873-5878
39. Increased EphB2 expression predicts cholangiocarcinoma metastasis Khansaard, W.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Puapairoj, A.
Loilome, W.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 10031-10041
40. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Techasen, A.
Loilome, W.
Namwat, N.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2014 Tumor Biology
9 (35), pp. 8645-8652
41. Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways in a cholangiocarcinogenesis model Yothaisong, S.
Thanee, M.
Namwat, N.
Yongvanit, P.
Boonmars, T.
Puapairoj, A.
Loilome, W.
2014 Asian Pacific Journal of Cancer Prevention
23 (15), pp. 10463-10468
42. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J.
Chusorn, P.
Techasen, A.
Loilome, W.
Boonmars, T.
Thanan, R.
Puapairoj, A.
Khuntikeo, N.
Tassaneeyakul, W.
Yongvanit, P.
Namwat, N.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-8064
43. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Dokduang, H.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Pairojkul, C.
Murakami, Y.
Loilome, W.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
10 (21), pp. 767-776
44. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Techasen, A.
Namwat, N.
Loilome, W.
Duangkumpha, K.
Puapairoj, A.
Saya, H.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
9 (21), pp. 703-711
45. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells Thongchot, S.
Loilome, W.
Yongvanit, P.
Dokduang, H.
Thanan, R.
Techasen, A.
Namwat, N.
2015 Asian Pacific Journal of Cancer Prevention
5 (16), pp. 2031-2035
46. Cohort profile: Cholangiocarcinoma screening and care program (CASCAP) Khuntikeo, N.
Chamadol, N.
Yongvanit, P.
Loilome, W.
Namwat, N.
Sithithaworn, P.
Andrews, R.H.
Petney, T.N.
Promthet, S.S.
Thinkhamrop, K.
Tawarungruang, C.
Thinkhamrop, B.
2015 BMC Cancer
1 (15), pp.
47. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wattanawongdon, W.
Hahnvajanawong, C.
Namwat, N.
Kanchanawat, S.
Boonmars, T.
Jearanaikoon, P.
Leelayuwat, C.
Techasen, A.
Seubwai, W.
2015 International Journal of Oncology
1 (47), pp. 398-410
48. Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Boonmars, T.
Pairojkul, C.
Yongvanit, P.
2015 Asian Pacific Journal of Cancer Prevention
7 (16), pp. 3043-3050
49. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Pairojkul, C.
Saya, H.
Yongvanit, P.
2016 Cancer Science
(), pp.
50. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Pairojkul, C.
Saya, H.
Yongvanit, P.
2016 Cancer Science
7 (107), pp. 991-1000
51. Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand Khuntikeo, N.
Sithithaworn, P.
Namwat, N.
Yongvanit, P.
Kiatsopit, N.
Andrews, R.H.
2016 Acta Tropica
(164), pp. 469-472
52. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma Sudsarn, P.
Boonmars, T.
Ruangjirachuporn, W.
Namwat, N.
Loilome, W.
Sriraj, P.
Aukkanimart, R.
Jiraporn, S.
2016 Pathology and Oncology Research
1 (22), pp. 57-65
53. Potential of selenium compounds as new anticancer agents for cholangiocarcinoma Thongchot, S.
Dokduang, H.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
Techasen, A.
Namwat, N.
2016 Anticancer Research
11 (36), pp. 5981-5988
54. Xanthohumol inhibits STAT3 activation pathway leaDing to growth suppression and apoptosis induction in human cholangiocarcinoma cells Dokduang, H.
Yongvanit, P.
Namwat, N.
Pairojkul, C.
Loilome, W.
2016 Oncology Reports
4 (35), pp. 2065-2072
55. Carcinogenic liver fluke and others contaminated in pickled fish of northeastern Thailand Aukkanimart, R.
Boonmars, T.
Sriraj, P.
Songsri, J.
Laummaunwai, P.
Aunpromma, S.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
Boonjaraspinyo, S.
2017 Asian Pacific Journal of Cancer Prevention
2 (18), pp. 529-533
56. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand Senggunprai, L.
Namwat, N.
Kongpetch, S.
Chamgramol, Y.
Loilome, W.
Khansaard, W.
Jusakul, A.
Prawan, A.
Pairojkul, C.
Yongvanit, P.
Kukongviriyapan, V.
2017 Tumor Biology
11 (39), pp.
57. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Loilome, W.
Yongvanit, P.
Namwat, N.
Techasen, A.
Khuntikeo, N.
2017 Oncology Letters
2 (13), pp. 639-646
58. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Namwat, N.
Yongvanit, P.
Loilome, W.
Khuntikeo, N.
Tassaneeyakul, W.
Tangsucharit, P.
Yothaisong, S.
2017 Parasitology International
4 (66), pp. 471-478
59. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Yothaisong, S.
Dokduang, H.
Namwat, N.
Yongvanit, P.
Loilome, W.
2017 Tumor Biology
3 (39), pp.
60. Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process Thanee, M.
Techasen, A.
Namwat, N.
Yongvanit, P.
Loilome, W.
2017 Anticancer Research
7 (37), pp. 3591-3597
61. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem Techasen, A.
Loilome, W.
Khuntikeo, N.
Yongvanit, P.
Sithithaworn, P.
2017 International Journal of General Medicine
(10), pp. 227-237
62. Simplified techniques for killing the carcinogenic, Opisthorchis viverrini metacercariae in cyprinid fish Boonmars, T.
Songsri, J.
Aukkanimart, R.
Sriraj, P.
Rattanasuwan, P.
Suwannatrai, A.
Aunpromma, S.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
Boonjaraspinyo, S.
2017 Asian Pacific Journal of Cancer Prevention
6 (18), pp. 1507-1511
63. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Koonmee, S.
Loilome, W.
2017 Parasitology International
4 (66), pp. 486-493
64. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Techasen, A.
Thongchot, S.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2017 Oncology Letters
5 (14), pp. 5973-5979
65. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool Jamnongkan, W.
Thanan, R.
Techasen, A.
Namwat, N.
Loilome, W.
Intarawichian, P.
Titapun, A.
Yongvanit, P.
2017 Tumor Biology
7 (39), pp. 1-10
66. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Loilome, W.
Yongvanit, P.
Thongchot, S.
Namwat, N.
Sithithaworn, P.
Boonmars, T.
Koonmee, S.
Titapun, A.
Khuntikeo, N.
Chamadol, N.
Techasen, A.
2017 Parasitology International
4 (66), pp. 479-485
67. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Jamnongkan, W.
Thanee, M.
Yongvanit, P.
Loilome, W.
Thanan, R.
Namwat, N.
Techasen, A.
2018 PeerJ
1 (2018), pp.
68. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway Thongchot, S.
Loilome,
Yongvanit, P.
2018 Molecular Carcinogenesis
12 (57), pp. 1735-1750
69. Erratum to “Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells” (Cancer Letters (2018) 430 (160–171), (S0304383518303641) (10.1016/j.canlet.2018.05.031)) Thongchot, S.
Loilome,
Yongvanit, P.
2018 Cancer Letters
(434), pp. 206-207
70. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018 FEBS Open Bio
4 (8), pp. 513-522
71. Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth Dokduang, H.
Yothaisong, S.
Techasen, A.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Loilome,
2018 Oncology Letters
2 (16), pp. 1627-1633
72. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Thongchot, S.
Loilome,
Techasen, A.
Ungarreevittaya, P.
Khuntikeo, N.
Yongvanit, P.
2018 PLoS ONE
6 (13), pp.
73. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Loilome, W.
Techasen, A.
Thanee, M.
Titapun, A.
Yongvanit, P.
Namwat, N.
2018 OncoTargets and Therapy
(11), pp. 395-408
74. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Armartmuntree, N.
Techasen, A.
Yongvanit, P.
Loilome, W.
Pairojkul, C.
Sakonsinsiri, C.
Pinlaor, S.
Thanan, R.
2018 Redox Biology
(14), pp. 637-644
75. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells Thongchot, S.
Loilome,
Yongvanit, P.
2018 Cancer Letters
(430), pp. 160-171
76. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine Techasen, A.
Thongchot, S.
Loilome, W.
Thanan, R.
Yongvanit, P.
Titapun, A.
Khuntikeo, N.
Namwat, N.
2018 Oncology Letters
1 (15), pp. 347-353
77. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma Sakonsinsiri, C.
Sawanyawisuth, K.
Ungarreevittaya, P.
Khuntikeo, N.
Armartmuntree, N.
Thanan, R.
2018 Hormones and Cancer
6 (9), pp. 408-419
78. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway Thanee, M.
Techasen, A.
Klanrit,
Titapun, A.
Loilome,
2018 OncoTargets and Therapy
(11), pp. 7019-7029
79. Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Duenngai, K.
Kiatsopit, N.
Kopolrat, K.
Techasen, A.
Sithithaworn, J.
Khuntikeo, N.
Loilome,
Yongvanit, P.
Sithithaworn, P.
2019 PLoS Neglected Tropical Diseases
2 (13), pp.
80. Detection of the G1138A mutation in the FGFR3 gene for the diagnosis of achondroplasia by allele-specific polymerase chain reaction Imtawil, K.J.
Loilome, W.
Tangrassameeprasert, R.
Wichajarn, K.
2019 Journal of the Medical Association of Thailand
6 (102), pp. 118-121
81. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019 Journal of Proteome Research
9 (18), pp. 3305-3316
82. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Promraksa, B.
Phetcharaburanin, J.
Techasen, A.
Boonsiri, P.
Loilome,
2019 PLoS ONE
5 (14), pp.
83. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Klanrit,
Phetcharaburanin, J.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Loilome,
2019 PLoS ONE
9 (14), pp.
84. PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells Titapun, A.
Loilome,
2019 Cancer Genomics and Proteomics
6 (16), pp. 543-552
85. Roles of zinc finger protein 423 in proliferation and invasion of cholangiocarcinoma through oxidative stress Armartmuntree, N.
Techasen, A.
Sakonsinsiri, C.
Pinlaor, S.
Ungarreevittaya, P.
Khuntikeo, N.
Thanan, R.
2019 Biomolecules
7 (9), pp.
86. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019 PLoS ONE
8 (14), pp.
87. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients Khuntikeo, N.
Koonmee, S.
Chamadol, N.
Laopaiboon, V.
Titapun, A.
Yongvanit, P.
Loilome,
Andrews, R.H.
Thinkhamrop, K.
Tawarungruang, C.
Thinkhamrop, B.
2020 HPB
6 (22), pp. 874-883
88. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma Thanee, M.
Namwat, N.
Phetcharaburanin, J.
Klanrit, P.
Khuntikeo, N.
Titapun, A.
Loilome, W.
2020 BMC Cancer
1 (20), pp.
89. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Jamnongkan, W.
Techasen, A.
Phetcharaburanin, J.
Sithithaworn, P.
Khuntikeo, N.
Mukdasai, S.
Sayasone, S.
Loilome, W.
Ngeontae, W.
2020 Talanta
(209), pp.
90. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Thongchot, S.
Thanee, M.
Loilome, W.
Techasen, A.
Titapun, A.
Yongvanit, P.
Namwat, N.
2020 Journal of Traditional and Complementary Medicine
3 (10), pp. 230-235
91. Evaluation of p53 and its target gene expression as potential biomarkers of cholangiocarcinoma in Thai patients Puetkasichonpasutha, J.
Namwat, N.
Titapun, A.
Suthiphongchai, T.
2020 Asian Pacific Journal of Cancer Prevention
3 (21), pp. 791-798
92. In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines Dokduang, H.
Promraksa, B.
Thanee, M.
Phetcharaburanin, J.
Namwat, N.
Titapun, A.
Khuntikeo, N.
Klanrit, P.
Loilome, W.
2020 Drug Design, Development and Therapy
(14), pp. 2319-2334
93. Liver fluke-infected cyprinoid fish in northeastern thailand (2016-2017) Pumhirunroj, B.
Aukkanimart, R.
Boonmars, T.
Sriraj, P.
Boueroy, P.
Artchayasawat, A.
Songsri, J.
Sripan, P.
Ratanasuwan, P.
Laummaunwai, P.
Khueangchaingkhwang, S.
Aunpromma, S.
Eamudomkarn, C.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
2020 Southeast Asian Journal of Tropical Medicine and Public Health
1 (51), pp. 1-7
94. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Thanee, M.
Phetcharaburanin, J.
Klanrit, P.
Khuntikeo, N.
Titapun, A.
Saya, H.
Loilome, W.
2020 Journal of Translational Medicine
1 (18), pp.
95. <sup>1</sup>H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination Phetcharaburanin, J.
Moolpia, K.
Suksawat, M.
Promraksa, B.
Klanrit, P.
Namwat, N.
Loilome, W.
Poopasit, K.
Katekaew, S.
Phetcharaburanin, P.
2020 PLoS ONE
12 December (15), pp.
96. A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples Jamnongkan, W.
Phetcharaburanin, J.
Klanrit, P.
Namwat, N.
Techasen, A.
Sithithaworn, P.
Khuntikeo, N.
Boonmars, T.
Loilome, W.
Ngeontae, W.
2021 Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
(254), pp.
97. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway Jusakul, A.
Kongpetch, S.
Kimawaha, P.
Klanrit, P.
Loilome, W.
Namwat, N.
Techasen, A.
2021 Naunyn-Schmiedeberg's Archives of Pharmacology
10 (394), pp. 2049-2059
98. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits Klanrit, P.
Hanboonsong, Y.
Yordpratum, U.
Suksawat, M.
Sermswan, R.W.
Namwat, N.
Loilome, W.
Khampitak, T.
Wangwiwatsin, A.
Phetcharaburanin, J.
2021 Scientific Reports
1 (11), pp.
99. Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse Thongchot, S.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Namwat, N.
2021 Cancers
9 (13), pp.
100. CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression Thanee, M.
Dokduang, H.
Phetcharaburanin, J.
Klanrit, P.
Titapun, A.
Namwat, N.
Khuntikeo, N.
Wangwiwatsin, A.
Saya, H.
Loilome, W.
2021 PLoS ONE
3 March (16), pp.
101. Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma Wintachai, P.
Techasen, A.
Lert-Itthiporn, W.
Kongpetch, S.
Loilome, W.
Titapun, A.
Namwat, N.
Khuntikeo, N.
Jusakul, A.
2021 Diagnostics
6 (11), pp.
102. Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction Kittirat, Y.
Phetcharaburanin, J.
Promraksa, B.
Wangwiwatsin, A.
Klanrit, P.
Sangkhamanon, S.
Jarearnrat, A.
Thongchot, S.
Mahalapbutr, P.
Loilome, W.
Saya, H.
Namwat, N.
2021 Frontiers in Public Health
(9), pp.
103. Metabolic changes of cholangiocarcinoma cells in response to coniferyl alcohol treatment Promraksa, B.
Katrun, P.
Phetcharaburanin, J.
Namwat, N.
Techasen, A.
Loilome, W.
2021 Biomolecules
3 (11), pp. 1-15
104. Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma Phetcharaburanin, J.
Namwat, N.
Klanrit, P.
Thanee, M.
Dokduang, H.
Loilome, W.
2021 Cancer Genomics and Proteomics
1 (18), pp. 29-42
105. Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples Taron, W.
Jamnongkan, W.
Techasen, A.
Phetcharaburanin, J.
Klanrit, P.
Namwat, N.
Khuntikeo, N.
Boonmars, T.
Sithithaworn, P.
Buranachai, C.
Loilome, W.
Ngeontae, W.
2021 Sensors and Actuators B: Chemical
(348), pp.
106. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression Dokduang, H.
Padthaisong, S.
Namwat, N.
Klanrit, P.
Phetcharaburanin, J.
Wangwiwatsin, A.
Khampitak, T.
Koonmee, S.
Titapun, A.
Khuntikeo, N.
Loilome, W.
2021 Frontiers in Pharmacology
(12), pp.
107. Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker Puetkasichonpasutha, J.
Namwat, N.
Titapun, A.
Suthiphongchai, T.
2022 ScienceAsia
4 (48), pp. 379-386
108. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles Suksawat, M.
Phetcharaburanin, J.
Wangwiwatsin, A.
Klanrit, P.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Jarearnrat, A.
Sangkhamanon, S.
Loilome, W.
2022 PeerJ
(10), pp.
109. Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma Kittirat, Y.
Suksawat, M.
Thongchot, S.
Padthaisong, S.
Phetcharaburanin, J.
Wangwiwatsin, A.
Klanrit, P.
Sangkhamanon, S.
Titapun, A.
Loilome, W.
Saya, H.
Namwat, N.
2022 Frontiers in Pharmacology
(13), pp.
110. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma Suksawat, M.
Phetcharaburanin, J.
Klanrit, P.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Wangwiwatsin, A.
Mahalapbutr, P.
Loilome, W.
2022 Frontiers in Public Health
(10), pp.
111. The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models Phukhum, P.
Phetcharaburanin, J.
Chaleekarn, K.
Kittirat, Y.
Kulthawatsiri, T.
Namwat, N.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Wangwiwatsin, A.
Khampitak, T.
Suksawat, M.
Klanrit, P.
2023 Scientific Reports
1 (13), pp.
112. Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia Wangwiwatsin, A.
Kulwong, S.
Phetcharaburanin, J.
Namwat, N.
Klanrit, P.
Loilome, W.
Maleewong, W.
Reid, A.J.
2023 Frontiers in Microbiology
(14), pp.
113. Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines Janthamala, S.
Promraksa, B.
Thanee, M.
Duenngai, K.
Jusakul, A.
Kongpetch, S.
Kraiklang, R.
Thanee, K.
Pinlaor, P.
Namwat, N.
Saya, H.
Techasen, A.
2024 BMC Complementary Medicine and Therapies
1 (24), pp.

Title Authors Year Journal title
1. Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. Gamage, SA
Tepsiri, N
Wilairat, P
Wojcik, SJ
Figgitt, DP
Ralph, RK
Denny, WA
1994 Journal of medicinal chemistry
10 (37), pp. 1486-94
2. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Boonla, C
Wongkham, S
Sheehan, JK
Wongkham, C
Bhudhisawasdi, V
Tepsiri, N
Pairojkul, C
2003 Cancer
7 (98), pp. 1438-43
3. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. Tepsiri, N
Chaturat, L
Sripa, B
Namwat, W
Wongkham, S
Bhudhisawasdi, V
Tassaneeyakul, W
2005 World journal of gastroenterology : WJG
18 (11), pp. 2748-53
4. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. Loilome, W
Yongvanit, P
Wongkham, C
Tepsiri, N
Sripa, B
Sithithaworn, P
Hanai, S
Miwa, M
2006 Molecular carcinogenesis
5 (45), pp. 279-87
5. Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion. Thuwajit, P
Chawengrattanachot, W
Thuwajit, C
Sripa, B
May, FE
Westley, BR
Tepsiri, NN
Paupairoj, A
Chau-In, S
2007 Hepatology research : the official journal of the Japan Society of Hepatology
4 (37), pp. 295-304
6. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. Namwat, N
Amimanan, P
Loilome, W
Jearanaikoon, P
Sripa, B
Bhudhisawasdi, V
Tassaneeyakul, W
2008 Chemotherapy
5 (54), pp. 343-51
7. Comparative study for the detection of C4d in paraffin-embedded renal allograft biopsies by immunohistochemical techniques. Phanomsri, EO
Namwat, N
Tangrassameeprasert, R
Charnteeraprawat, C
Paupiroj, A
2010 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(93), pp. S61-8
8. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Techasen, A
Loilome, W
Namwat, N
Takahashi, E
Sugihara, E
Puapairoj, A
Miwa, M
Saya, H
Yongvanit, P
2010 Cancer science
3 (101), pp. 658-65
9. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. Hahnvajanawong, C
Boonyanugomol, W
Nasomyon, T
Loilome, W
Namwat, N
Anantachoke, N
Tassaneeyakul, W
Sripa, B
Namwat, W
Reutrakul, V
2010 World journal of gastroenterology : WJG
18 (16), pp. 2235-43
10. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. Loilome, W
Juntana, S
Namwat, N
Bhudhisawasdi, V
Puapairoj, A
Sripa, B
Miwa, M
Saya, H
Riggins, GJ
Yongvanit, P
2011 International journal of cancer. Journal international du cancer
1 (129), pp. 34-44
11. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. Namwat, N
Puetkasichonpasutha, J
Loilome, W
Yongvanit, P
Techasen, A
Puapairoj, A
Sripa, B
Tassaneeyakul, W
Khuntikeo, N
Wongkham, S
2011 Journal of gastroenterology
5 (46), pp. 664-75
12. Mechanisms of oxysterol-induced carcinogenesis. Jusakul, A
Yongvanit, P
Loilome, W
Namwat, N
Kuver, R
2011 Lipids in health and disease
(10), pp. 44
13. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma. Namwat, N
Chusorn, P
Loilome, W
Techasen, A
Puetkasichonpasutha, J
Pairojkul, C
Khuntikeo, N
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 65-9
14. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Loilome, W
Yooyuen, S
Namwat, N
Sithithaworn, P
Puapairoj, A
Kano, J
Noguchi, M
Miwa, M
Yongvanit, P
2012 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (33), pp. 2289-98
15. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. Hahnvajanawong, C
Chaiyagool, J
Seubwai, W
Bhudhisawasdi, V
Namwat, N
Khuntikeo, N
Sripa, B
Pugkhem, A
Tassaneeyakul, W
2012 World journal of gastroenterology : WJG
30 (18), pp. 3955-61
16. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Techasen, A
Namwat, N
Loilome, W
Bungkanjana, P
Khuntikeo, N
Puapairoj, A
Jearanaikoon, P
Saya, H
Yongvanit, P
2012 Medical oncology (Northwood, London, England)
5 (29), pp. 3083-91
17. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. Loilome, W
Kadsanit, S
Namwat, N
Techasen, A
Puapairoj, A
Dechakhamphu, A
Pinitsoontorn, C
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 59-64
18. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. Techasen, A
Loilome, W
Namwat, N
Dokduang, H
Jongthawin, J
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 115-8
19. Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. Jongthawin, J
Techasen, A
Loilome, W
Yongvanit, P
Namwat, N
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 47-51
20. Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. Loilome, W
Juntana, S
Pinitsoontorn, C
Namwat, N
Tassaneeyakul, W
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 143-7
21. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. Jusakul, A
Khuntikeo, N
Haigh, WG
Kuver, R
Ioannou, GN
Loilome, W
Namwat, N
Bhudhisawasdi, V
Pugkhem, A
Pairojkul, C
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 77-82
22. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. Yongvanit, P
Thanan, R
Pinlaor, S
Sithithaworn, P
Loilome, W
Namwat, N
Techasen, A
Dechakhamphu, S
2012 Parasitology research
5 (110), pp. 1969-77
23. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Jusakul, A
Loilome, W
Namwat, N
Haigh, WG
Kuver, R
Dechakhamphu, S
Sukontawarin, P
Pinlaor, S
Lee, SP
Yongvanit, P
2012 Mutation research
1 (731), pp. 48-57
24. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. Techasen, A
Loilome, W
Namwat, N
Duenngai, K
Cha'on, U
Thanan, R
Sithithaworn, P
Miwa, M
Yongvanit, P
2012 Parasitology international
1 (61), pp. 140-4
25. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis. Loilome, W
Wechagama, P
Namwat, N
Jusakul, A
Sripa, B
Miwa, M
Kuver, R
Yongvanit, P
2012 Parasitology international
1 (61), pp. 136-9
26. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. Yongvanit, P
Phanomsri, E
Namwat, N
Kampan, J
Tassaneeyakul, W
Loilome, W
Puapairoj, A
Khuntikeo, N
2012 Parasitology international
1 (61), pp. 162-6
27. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong, S
Dokduang, H
Techasen, A
Namwat, N
Yongvanit, P
Bhudhisawasdi, V
Puapairoj, A
Riggins, GJ
Loilome, W
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (34), pp. 3637-48
28. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. Dokduang, H
Juntana, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Riggins, GJ
Loilome, W
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (34), pp. 3519-28
29. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Chusorn, P
Namwat, N
Loilome, W
Techasen, A
Pairojkul, C
Khuntikeo, N
Dechakhamphu, A
Talabnin, C
Chan-On, W
Ong, CK
Teh, BT
Yongvanit, P
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (34), pp. 1579-88
30. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Jamnongkan, W
Techasen, A
Thanan, R
Duenngai, K
Sithithaworn, P
Mairiang, E
Loilome, W
Namwat, N
Pairojkul, C
Yongvanit, P
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2 (34), pp. 695-704
31. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine. Juasook, A
Boonmars, T
Wu, Z
Loilome, W
Veteewuthacharn, K
Namwat, N
Sudsarn, P
Wonkchalee, O
Sriraj, P
Aukkanimart, R
2013 Pathology oncology research : POR
1 (19), pp. 55-62
32. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. Jusakul, A
Loilome, W
Namwat, N
Techasen, A
Kuver, R
Ioannou, GN
Savard, C
Haigh, WG
Yongvanit, P
2013 The Journal of steroid biochemistry and molecular biology
(138), pp. 368-75
33. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. Silakit, R
Loilome, W
Yongvanit, P
Chusorn, P
Techasen, A
Boonmars, T
Khuntikeo, N
Chamadol, N
Pairojkul, C
Namwat, N
2014 Journal of hepato-biliary-pancreatic sciences
12 (21), pp. 864-72
34. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Loilome, W
Bungkanjana, P
Techasen, A
Namwat, N
Yongvanit, P
Puapairoj, A
Khuntikeo, N
Riggins, GJ
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (35), pp. 5357-67
35. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Techasen, A
Loilome, W
Namwat, N
Khuntikeo, N
Puapairoj, A
Jearanaikoon, P
Saya, H
Yongvanit, P
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
9 (35), pp. 8645-52
36. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. Techasen, A
Namwat, N
Loilome, W
Duangkumpha, K
Puapairoj, A
Saya, H
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
9 (21), pp. 703-11
37. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Thongchot, S
Yongvanit, P
Loilome, W
Seubwai, W
Phunicom, K
Tassaneeyakul, W
Pairojkul, C
Promkotra, W
Techasen, A
Namwat, N
2014 Asian Pacific journal of cancer prevention : APJCP
14 (15), pp. 5873-8
38. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. Duangkumpha, K
Techasen, A
Loilome, W
Namwat, N
Thanan, R
Khuntikeo, N
Yongvanit, P
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 9667-76
39. Increased EphB2 expression predicts cholangiocarcinoma metastasis. Khansaard, W
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Loilome, W
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 10031-41
40. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. Dokduang, H
Techasen, A
Namwat, N
Khuntikeo, N
Pairojkul, C
Murakami, Y
Loilome, W
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
10 (21), pp. 767-76
41. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-64
42. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Khenjanta, C
Thanan, R
Jusakul, A
Techasen, A
Jamnongkan, W
Namwat, N
Loilome, W
Pairojkul, C
Yongvanit, P
2014 Asian Pacific journal of cancer prevention : APJCP
23 (15), pp. 10187-92
43. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model. Yothaisong, S
Thanee, M
Namwat, N
Yongvanit, P
Boonmars, T
Puapairoj, A
Loilome, W
2014 Asian Pacific journal of cancer prevention : APJCP
23 (15), pp. 10463-8
44. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. Thongchot, S
Loilome, W
Yongvanit, P
Dokduang, H
Thanan, R
Techasen, A
Namwat, N
2015 Asian Pacific journal of cancer prevention : APJCP
5 (16), pp. 2031-5
45. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. Worasith, C
Kamamia, C
Yakovleva, A
Duenngai, K
Wangboon, C
Sithithaworn, J
Watwiengkam, N
Namwat, N
Techasen, A
Loilome, W
Yongvanit, P
Loukas, A
Sithithaworn, P
Bethony, JM
2015 PLoS neglected tropical diseases
10 (9), pp. e0004157
46. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). ,
Khuntikeo, N
Chamadol, N
Yongvanit, P
Loilome, W
Namwat, N
Sithithaworn, P
Andrews, RH
Petney, TN
Promthet, S
Thinkhamrop, K
Tawarungruang, C
Thinkhamrop, B
,
,
,
,
,
,
,
,
,
2015 BMC cancer
(15), pp. 459
47. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. Wattanawongdon, W
Hahnvajanawong, C
Namwat, N
Kanchanawat, S
Boonmars, T
Jearanaikoon, P
Leelayuwat, C
Techasen, A
Seubwai, W
2015 International journal of oncology
1 (47), pp. 398-410
48. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. Thanee, M
Loilome, W
Techasen, A
Namwat, N
Boonmars, T
Pairojkul, C
Yongvanit, P
2015 Asian Pacific journal of cancer prevention : APJCP
7 (16), pp. 3043-50
49. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Dokduang, H
Yongvanit, P
Namwat, N
Pairojkul, C
Sangkhamanon, S
Yageta, MS
Murakami, Y
Loilome, W
2016 Oncology reports
4 (35), pp. 2065-72
50. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. Dai, X
Thongchot, S
Dokduang, H
Loilome, W
Khuntikeo, N
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Techasen, A
Namwat, N
2016 Anticancer research
11 (36), pp. 5981-5988
51. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. Thanee, M
Loilome, W
Techasen, A
Sugihara, E
Okazaki, S
Abe, S
Ueda, S
Masuko, T
Namwat, N
Khuntikeo, N
Titapun, A
Pairojkul, C
Saya, H
Yongvanit, P
2016 Cancer science
7 (107), pp. 991-1000
52. Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand. Khuntikeo, N
Sithithaworn, P
Loilom, W
Namwat, N
Yongvanit, P
Thinkhamrop, B
Kiatsopit, N
Andrews, RH
Petney, TN
2016 Acta tropica
(164), pp. 469-472
53. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. Sudsarn, P
Boonmars, T
Ruangjirachuporn, W
Namwat, N
Loilome, W
Sriraj, P
Aukkanimart, R
Nadchanan, W
Jiraporn, S
2016 Pathology oncology research : POR
1 (22), pp. 57-65
54. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Armartmuntree, N
Murata, M
Techasen, A
Yongvanit, P
Loilome, W
Namwat, N
Pairojkul, C
Sakonsinsiri, C
Pinlaor, S
Thanan, R
2017 Redox biology
(14), pp. 637-644
55. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. Silakit, R
Loilome, W
Yongvanit, P
Thongchot, S
Sithithaworn, P
Boonmars, T
Koonmee, S
Titapun, A
Khuntikeo, N
Chamadol, N
Techasen, A
Namwat, N
2017 Parasitology international
4 (66), pp. 479-485
56. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Yothaisong, S
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Jutabha, P
Anzai, N
Tassaneeyakul, W
Tangsucharit, P
Loilome, W
2017 Parasitology international
4 (66), pp. 471-478
57. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Suksawat, M
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Koonmee, S
Loilome, W
2017 Parasitology international
4 (66), pp. 486-493
58. Carcinogenic Liver Fluke and Others Contaminated in Pickled Fish of Northeastern Thailand Aukkanimart, R
Boonmars, T
Sriraj, P
Sripan, P
Songsri, J
Ratanasuwan, P
Laummaunwai, P
Suwanantrai, A
Aunpromma, S
Khueangchaingkhwang, S
Pumhirunroj, B
Artchayasawat, A
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Boonjaraspinyo, S
2017 Asian Pacific journal of cancer prevention : APJCP
2 (18), pp. 529-533
59. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. Loilome, W
Kadsanit, S
Muisook, K
Yongvanit, P
Namwat, N
Techasen, A
Puapairoj, A
Khuntikeo, N
Phonjit, P
2017 Oncology letters
2 (13), pp. 639-646
60. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. Yothaisong, S
Dokduang, H
Anzai, N
Hayashi, K
Namwat, N
Yongvanit, P
Sangkhamanon, S
Jutabha, P
Endou, H
Loilome, W
2017 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (39), pp. 1010428317694545
61. Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish Sripan, P
Boonmars, T
Songsri, J
Aukkanimart, R
Sriraj, P
Rattanasuwan, P
Boueroy, P
Suwannatrai, A
Aunpromma, S
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
PhyoWai, A
Khueangchaingkhwang, S
Zhilang, W
Pumhirunroj, B
Artchayasawat, A
Boonjaraspinyo, S
2017 Asian Pacific journal of cancer prevention : APJCP
6 (18), pp. 1507-1511
62. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. Jamnongkan, W
Thanan, R
Techasen, A
Namwat, N
Loilome, W
Intarawichian, P
Titapun, A
Yongvanit, P
2017 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
7 (39), pp. 1010428317717655
63. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Padthaisong, S
Thanee, M
Techasen, A
Namwat, N
Yongvanit, P
Liwatthakun, A
Hankla, K
Sangkhamanon, S
Loilome, W
2017 Anticancer research
7 (37), pp. 3591-3597
64. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem. Hughes, T
O'Connor, T
Techasen, A
Namwat, N
Loilome, W
Andrews, RH
Khuntikeo, N
Yongvanit, P
Sithithaworn, P
Taylor-Robinson, SD
2017 International journal of general medicine
(10), pp. 227-237
65. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. Jamnongkan, W
Thanee, M
Yongvanit, P
Loilome, W
Thanan, R
Kimawaha, P
Boonmars, T
Silakit, R
Namwat, N
Techasen, A
2018 PeerJ
(6), pp. e4281
66. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018 Oncology letters
1 (15), pp. 347-353
67. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. Daya, M
Loilome, W
Techasen, A
Thanee, M
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Namwat, N
2018 OncoTargets and therapy
(11), pp. 395-408
68. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. Suksawat, M
Techasen, A
Namwat, N
Boonsong, T
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Loilome, W
2018 FEBS open bio
4 (8), pp. 513-522
69. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018 Cancer letters
(430), pp. 160-171
70. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. Silakit, R
Kitirat, Y
Thongchot, S
Loilome, W
Techasen, A
Ungarreevittaya, P
Khuntikeo, N
Yongvanit, P
Yang, JH
Kim, NH
Yook, JI
Namwat, N
2018 PloS one
6 (13), pp. e0199827
71. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Padthaisong, S
Dokduang, H
Yothaisong, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Sangkhamanon, S
Loilome, W
2018 Oncology letters
2 (16), pp. 1627-1633
72. Erratum to "Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells" [Cancer Letters 430C (2018) 160-171]. Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018 Cancer letters
(434), pp. 206-207
73. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma. Kaewlert, W
Sakonsinsiri, C
Namwat, N
Sawanyawisuth, K
Ungarreevittaya, P
Khuntikeo, N
Armartmuntree, N
Thanan, R
2018 Hormones & cancer
6 (9), pp. 408-419
74. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway. Thongchot, S
Vidoni, C
Ferraresi, A
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018 Molecular carcinogenesis
12 (57), pp. 1735-1750
75. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. Khophai, S
Thanee, M
Techasen, A
Namwat, N
Klanrit, P
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Loilome, W
2018 OncoTargets and therapy
(11), pp. 7019-7029
76. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. Worasith, C
Wangboon, C
Duenngai, K
Kiatsopit, N
Kopolrat, K
Techasen, A
Sithithaworn, J
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Carlton, EJ
Sithithaworn, P
2019 PLoS neglected tropical diseases
2 (13), pp. e0007186
77. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. Promraksa, B
Phetcharaburanin, J
Namwat, N
Techasen, A
Boonsiri, P
Loilome, W
2019 PloS one
5 (14), pp. e0216721
78. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019 PloS one
8 (14), pp. e0221024
79. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019 Journal of proteome research
9 (18), pp. 3305-3316
80. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. Suksawat, M
Klanrit, P
Phetcharaburanin, J
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Techasen, A
Loilome, W
2019 PloS one
9 (14), pp. e0222140
81. PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. Piyawajanusorn, C
Kittirat, Y
Sa-Ngiamwibool, P
Titapun, A
Loilome, W
Namwat, N
2019 Cancer genomics & proteomics
6 (16), pp. 543-552
82. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. Taron, W
Jamnongkan, W
Techasen, A
Phetcharaburanin, J
Namwat, N
Sithithaworn, P
Khuntikeo, N
Mukdasai, S
Sayasone, S
Loilome, W
Ngeontae, W
2020 Talanta
(209), pp. 120592
83. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Sungkhamanon, S
Saya, H
Loilome, W
2020 Journal of translational medicine
1 (18), pp. 64
84. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Loilome, W
2020 BMC cancer
1 (20), pp. 154
85. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients. Puetkasichonpasutha, J
Namwat, N
Sa-Ngiamwibool, P
Titapun, A
Suthiphongchai, T
2020 Asian Pacific journal of cancer prevention : APJCP
3 (21), pp. 791-798
86. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. Khuntikeo, N
Koonmee, S
Sa-Ngiamwibool, P
Chamadol, N
Laopaiboon, V
Titapun, A
Yongvanit, P
Loilome, W
Namwat, N
Andrews, RH
Petney, TN
Thinkhamrop, K
Chaichaya, N
Tawarungruang, C
Thuanman, J
Thinkhamrop, B
2020 HPB : the official journal of the International Hepato Pancreato Biliary Association
6 (22), pp. 874-883
87. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. Dokduang, H
Jamnongkarn, W
Promraksa, B
Suksawat, M
Padthaisong, S
Thanee, M
Phetcharaburanin, J
Namwat, N
Sangkhamanon, S
Titapun, A
Khuntikeo, N
Klanrit, P
Loilome, W
2020 Drug design, development and therapy
(14), pp. 2319-2334
88. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. Thongchot, S
Thanee, M
Loilome, W
Techasen, A
Boonmars, T
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Isidoro, C
Namwat, N
2020 Journal of traditional and complementary medicine
3 (10), pp. 230-235
89. 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. Phetcharaburanin, J
Deewai, S
Kulthawatsiri, T
Moolpia, K
Suksawat, M
Promraksa, B
Klanrit, P
Namwat, N
Loilome, W
Poopasit, K
Katekaew, S
Phetcharaburanin, P
2020 PloS one
12 (15), pp. e0243432
90. Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. Prommajun, P
Phetcharaburanin, J
Namwat, N
Klanrit, P
Sa-Ngiamwibool, P
Thanee, M
Dokduang, H
Kittirat, Y
Li, JV
Loilome, W
2021 Cancer genomics & proteomics
1 (18), pp. 29-42
91. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. Thanee, M
Padthaisong, S
Suksawat, M
Dokduang, H
Phetcharaburanin, J
Klanrit, P
Titapun, A
Namwat, N
Wangwiwatsin, A
Sa-Ngiamwibool, P
Khuntikeo, N
Saya, H
Loilome, W
2021 Cancer & metabolism
1 (9), pp. 11
92. A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples. Taron, W
Jamnongkan, W
Phetcharaburanin, J
Klanrit, P
Namwat, N
Techasen, A
Sithithaworn, P
Khuntikeo, N
Boonmars, T
Loilome, W
Ngeontae, W
2021 Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
(254), pp. 119633
93. CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. Thanee, M
Dokduang, H
Kittirat, Y
Phetcharaburanin, J
Klanrit, P
Titapun, A
Namwat, N
Khuntikeo, N
Wangwiwatsin, A
Saya, H
Loilome, W
2021 PloS one
3 (16), pp. e0245871
94. Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. Padthaisong, S
Phetcharaburanin, J
Klanrit, P
Li, JV
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Wangwiwatsin, A
Mahalapbutr, P
Loilome, W
2021 Cancer & metabolism
1 (9), pp. 30
95. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. Tomacha, J
Dokduang, H
Padthaisong, S
Namwat, N
Klanrit, P
Phetcharaburanin, J
Wangwiwatsin, A
Khampitak, T
Koonmee, S
Titapun, A
Jarearnrat, A
Khuntikeo, N
Loilome, W
2021 Frontiers in pharmacology
(12), pp. 696961
96. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Janthamala, S
Jusakul, A
Kongpetch, S
Kimawaha, P
Klanrit, P
Loilome, W
Namwat, N
Techasen, A
2021 Naunyn-Schmiedeberg's archives of pharmacology
10 (394), pp. 2049-2059
97. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. Ho, PN
Klanrit, P
Hanboonsong, Y
Yordpratum, U
Suksawat, M
Kulthawatsiri, T
Jirahiranpat, A
Deewai, S
Mackawan, P
Sermswan, RW
Namwat, N
Loilome, W
Khampitak, T
Wangwiwatsin, A
Phetcharaburanin, J
2021 Scientific reports
1 (11), pp. 23316
98. Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. Kittirat, Y
Phetcharaburanin, J
Promraksa, B
Kulthawatsiri, T
Wangwiwatsin, A
Klanrit, P
Sangkhamanon, S
Jarearnrat, A
Thongchot, S
Mahalapbutr, P
Loilome, W
Saya, H
Namwat, N
2021 Frontiers in public health
(9), pp. 766455
99. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. Suksawat, M
Phetcharaburanin, J
Klanrit, P
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Vilayhong, V
Sa-Ngiamwibool, P
Techasen, A
Wangwiwatsin, A
Mahalapbutr, P
Li, JV
Loilome, W
2022 Frontiers in public health
(10), pp. 766023
100. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. Sitthirak, S
Suksawat, M
Phetcharaburanin, J
Wangwiwatsin, A
Klanrit, P
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sangkhamanon, S
Loilome, W
2022 PeerJ
(10), pp. e13876
101. Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. Kittirat, Y
Suksawat, M
Thongchot, S
Padthaisong, S
Phetcharaburanin, J
Wangwiwatsin, A
Klanrit, P
Sangkhamanon, S
Titapun, A
Loilome, W
Saya, H
Namwat, N
2022 Frontiers in pharmacology
(13), pp. 897368
102. The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. Phukhum, P
Phetcharaburanin, J
Chaleekarn, K
Kittirat, Y
Kulthawatsiri, T
Namwat, N
Loilome, W
Khuntikeo, N
Titapun, A
Wangwiwatsin, A
Khampitak, T
Suksawat, M
Klanrit, P
2023 Scientific reports
1 (13), pp. 3072
103. Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and . Wangwiwatsin, A
Kulwong, S
Phetcharaburanin, J
Namwat, N
Klanrit, P
Loilome, W
Maleewong, W
Reid, AJ
2023 Frontiers in microbiology
(14), pp. 1052352
104. H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. Treeriya, R
Ho, PN
Titapun, A
Klanrit, P
Suksawat, M
Kulthawatsiri, T
Sirirattanakul, S
Loilome, W
Namwat, N
Wangwiwatsin, A
Chamadol, N
Khuntikeo, N
Phetcharaburanin, J
2023 PeerJ
(11), pp. e15386
105. Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. Worasith, C
Sithithaworn, J
Wongphutorn, P
Homwong, C
Khongsukwiwat, K
Techasen, A
Kopolrat, KY
Loilome, W
Namwat, N
Thinkamrop, B
Tawarungruang, C
Titapun, A
Laha, T
Andrews, RH
Taylor-Robinson, SD
Sithithaworn, P
2023 Infectious diseases of poverty
1 (12), pp. 102
106. Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. Kulthawatsiri, T
Kittirat, Y
Phetcharaburanin, J
Tomacha, J
Promraksa, B
Wangwiwatsin, A
Klanrit, P
Titapun, A
Loilome, W
Namwat, N
2023 PeerJ
(11), pp. e16512
107. The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility. Loilome, W
Namwat, N
Jusakul, A
Techasen, A
Klanrit, P
Phetcharaburanin, J
Wangwiwatsin, A
2023 Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
(219), pp. 53-90
108. Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. Thongchot, S
Ferraresi, A
Vidoni, C
Salwa, A
Vallino, L
Kittirat, Y
Loilome, W
Namwat, N
Isidoro, C
2023 Cancer letters
(582), pp. 216589
109. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Islam, K
Balasubramanian, B
Venkatraman, S
Thummarati, P
Tunganuntarat, J
Phueakphud, N
Kanjanasirirat, P
Khumpanied, T
Kongpracha, P
Kittirat, Y
Tohtong, R
Janvilisri, T
Wongtrakoongate, P
Borwornpinyo, S
Namwat, N
Suthiphongchai, T
2023 Scientific reports
1 (13), pp. 22598
110. Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines. Janthamala, S
Promraksa, B
Thanee, M
Duenngai, K
Jusakul, A
Kongpetch, S
Kraiklang, R
Thanee, K
Pinlaor, P
Namwat, N
Saya, H
Techasen, A
2024 BMC complementary medicine and therapies
1 (24), pp. 178
111. Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells. Islam, K
Balasubramanian, B
Venkatraman, S
Thummarati, P
Tunganuntarat, J
Phueakphud, N
Kanjanasirirat, P
Khumpanied, T
Kongpracha, P
Kittirat, Y
Tohtong, R
Janvilisri, T
Wongtrakoongate, P
Borwornpinyo, S
Namwat, N
Suthiphongchai, T
2024 Scientific reports
1 (14), pp. 21696
112. Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. Thanasukarn, V
Srisuk, T
Luvira, V
Tipwaratorn, T
Jareanrat, A
Rattanarak, K
Kraphunpongsakul, K
Khuntikeo, N
Chindaprasirt, J
Sanlung, T
Chamadol, N
Koonmee, S
Sa-Ngiamwibool, P
Klanrit, P
Wangwiwatsin, A
Namwat, N
Loilome, W
Muangritdech, N
Prajumwongs, P
Watanabe, N
Ebata, T
Titapun, A
2024 World journal of surgical oncology
1 (22), pp. 287
113. Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. Thongyoo, P
Chindaprasirt, J
Aphivatanasiri, C
Intarawichian, P
Kunprom, W
Kongpetch, S
Techasen, A
Loilome, W
Namwat, N
Titapun, A
Jusakul, A
2025 Cancer genomics & proteomics
1 (22), pp. 112-126
114. Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. Thanasukarn, V
Prajumwongs, P
Muangritdech, N
Loilome, W
Namwat, N
Klanrit, P
Wangwiwatsin, A
Charoenlappanit, S
Jaresitthikunchai, J
Roytrakul, S
Titapun, A
2025 Scientific reports
1 (15), pp. 2582
115. Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (). Dokduang, H
Katenak, A
Kittirat, Y
Tomacha, J
Promraksa, B
Taing, L
Na Nakorn, S
Klanrit, P
Namwat, N
Titapun, A
Loilome, W
2025 Natural product research
(), pp. 1-8
116. Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. Dokduang, H
Jarernrat, A
Titapun, A
Sitthirak, S
Padthaisong, S
Kittirat, Y
Sangkamanon, S
Sa-Ngiamwibool, P
Wangwiwatsin, A
Klanrit, P
Namwat, N
Jusakul, A
Murakami, Y
Loilome, W
2025 Anticancer research
2 (45), pp. 579-592
117. The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. Wangwiwatsin, A
Kulwong, S
Phuyao, C
Titapun, A
Loilome, W
Klanrit, P
Namwat, N
Sithithaworn, P
Doyle, SR
Berriman, M
Crellen, T
,
,
,
,
2025 Wellcome open research
(10), pp. 1
118. Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. Jaidee, R
Jusakul, A
Pocasap, P
Kukongviriyapan, V
Senggunprai, L
Prawan, A
Loilome, W
Titapun, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Namwat, N
Chamgramol, Y
Thanee, M
Wichian, P
Hong, JH
Guan, P
Heng, HL
Pairojkul, C
Teh, BT
Kongpetch, S
2025 Scientific reports
1 (15), pp. 8621
119. Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. Prajumwongs, P
Titapun, A
Thanasukarn, V
Jareanrat, A
Khuntikeo, N
Namwat, N
Klanrit, P
Wangwiwatsin, A
Chindaprasirt, J
Koonmee, S
Sa-Ngiamwibool, P
Muangritdech, N
Roytrakul, S
Loilome, W
2025 Scientific reports
1 (15), pp. 12782
120. Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. Sitthirak, S
Wangwiwatsin, A
Jusakul, A
Namwat, N
Klanrit, P
Dokduang, H
Sa-Ngiamwibool, P
Titapun, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Teh, BT
Boulter, L
Murakami, Y
Loilome, W
2025 Scientific reports
1 (15), pp. 10886
121. Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. Win, ZZ
Dokduang, H
Kulwong, S
Loilome, W
Namwat, N
Phetcharaburanin, J
Wongsurawat, T
Jenjaroenpun, P
Klanrit, P
Wangwiwatsin, A
2025 PloS one
5 (20), pp. e0322173
122. Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. Sitthirak, S
Roytrakul, S
Wangwiwatsin, A
Namwat, N
Klanrit, P
Dokduang, H
Sa-Ngiamwibool, P
Titapan, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Boulter, L
Loilome, W
2025 Scientific reports
1 (15), pp. 17228
123. Mitochondrial genomic alterations in cholangiocarcinoma cell lines. Faipan, A
Sitthirak, S
Wangwiwatsin, A
Namwat, N
Klanrit, P
Titapun, A
Jareanrat, A
Thanasukarn, V
Khuntikeo, N
Boulter, L
Dokduang, H
Loilome, W
2025 PloS one
6 (20), pp. e0323844
124. Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. Taron, W
Jamnongkan, W
Kamjanlard, C
Phetcharaburanin, J
Wangwiwatsin, A
Klanrit, P
Namwat, N
Techasen, A
Titapun, A
Boonmars, T
Laummaunwai, P
Sithithaworn, P
Ngeontae, W
Loilome, W
2025 Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
(343), pp. 126589
125. Metabolomic analysis of bioactive compounds in dill ( L.) extracts. Thanuma, J
Phetcharaburanin, J
Dokduang, H
Loilome, W
Klanrit, P
Wangwiwatsin, A
Namwat, N
2025 PeerJ
(13), pp. e19567
126. Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection. Kopolrat, KY
Worasith, C
Wongphutorn, P
Techasen, A
Eamudomkarn, C
Sithithaworn, J
Loilome, W
Namwat, N
Titapun, A
Tawarungruang, C
Thinkhamrop, B
Futrakul, S
Taylor-Robinson, SD
Haswell, MR
Khuntikeo, N
Crellen, T
Sithithaworn, P
2025 PLoS neglected tropical diseases
7 (19), pp. e0013095

Title Authors Year Journal title Cited count
< 2020 2021 2022 2023 2024 2025 Total
1. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma C Boonla
S Wongkham
JK Sheehan
C Wongkham
V Bhudhisawasdi
N Tepsiri
C Pairojkul
2003 CANCER
7.0 (98.0), pp. 1438.0-1443.0
71 0 0 0 0 0 71
2. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines Nisana Tepsiri
Liengchai Chaturat
Banchob Sripa
Wises Namwat
Sopit Wongkham
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2005 WORLD JOURNAL OF GASTROENTEROLOGY
18.0 (11.0), pp. 2748.0-2753.0
71 0 0 0 0 0 71
3. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model W Loilome
P Yongvanit
C Wongkham
N Tepsiri
B Sripa
P Sithithaworn
S Hanai
M Miwa
2006 MOLECULAR CARCINOGENESIS
5.0 (45.0), pp. 279.0-287.0
80 0 0 0 0 0 80
4. Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines Nisana N. Tepsiri
Watcharin Loilome
Piyawan Amimanan
Patcharee Jearanaikoon
Wichittra Tassaneeyakul
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A95-A95
0 0 0 0 0 0 0
5. Plasma 8-isoprostane: a new biomarker in opisthorchiasis-associated cholangiocarcinoma Puangrat Yongvanit
Somkid Dechakhamphu
Somchai Pinlaor
Nisana N. Tepsiri
Watcharin Loilome
Narong Khantekaew
Paiboon Sithithaworn
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A187-A188
0 0 0 0 0 0 0
6. Prkar1a gene overexpression in liver tissue with cholangiocarcinoma Watcharin Loilome
Anucha Puapairoj
Nisana N. Tepsiri
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A188-A188
0 0 0 0 0 0 0
7. Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion Peti Thuwajit
Watinee Chawengrattanachot
Chanitra Thuwajit
Banchob Sripa
Felicity E. B. May
Bruce R. Westley
Nisana N. Tepsiri
Anucha Paupairoj
Siri Chau-in
2007 HEPATOLOGY RESEARCH
4.0 (37.0), pp. 295.0-304.0
21 0 0 0 0 0 21
8. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Nisana Namwat
Piyawan Amimanan
Watcharin Loilome
Patcharee Jearanaikoon
Banchob Sripa
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2008 CHEMOTHERAPY
5.0 (54.0), pp. 343.0-351.0
48 0 0 0 0 0 48
9. Over-expression of PRKAR1A in hepatic progenitor cells during cholangiocarcinogenesis induced by liver fluke (Opisthorchis, viverrini) P. Yonavanit
N. Namwat
W. Loilome
R. Thanan
E. Phanomsri
C. Pairojkul
2008 EJC SUPPLEMENTS
9.0 (6.0), pp. 132.0-133.0
0 0 0 0 0 0 0
10. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Chariya Hahnvajanawong
Wongwarut Boonyanugomol
Tapanawan Nasomyon
Watcharin Loilome
Nisana Namwat
Natthinee Anantachoke
Wichittra Tassaneeyakul
Banchob Sripa
Wises Namwat
Vichai Reutrakul
2010 WORLD JOURNAL OF GASTROENTEROLOGY
18.0 (16.0), pp. 2235.0-2243.0
39 0 0 0 0 0 39
11. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Eri Takahashi
Eiji Sugihara
Anucha Puapairoj
Masanao Miwa
Hideyuki Saya
Puangrat Yongvanit
2010 CANCER SCIENCE
3.0 (101.0), pp. 658.0-665.0
74 0 0 0 0 0 74
12. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011 JOURNAL OF GASTROENTEROLOGY
5.0 (46.0), pp. 664.0-675.0
53 0 0 0 0 0 53
13. Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines Chariya Hahnvajanawong
Supaluk Ketnimit
Wongwarut Boonyanugomol
Kovit Pattanapanyasat
Yaovalux Chamgramol
Banchob Sripa
Nisana Namwat
Khosit Pinmai
Wichittra Tassaneeyakul
Vichai Reutakul
2011 ASIAN BIOMEDICINE
6.0 (5.0), pp. 775.0-785.0
5 0 0 0 0 0 5
14. Mechanisms of oxysterol-induced carcinogenesis Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Rahul Kuver
2011 LIPIDS IN HEALTH AND DISEASE
(10.0), pp.
58 0 0 0 0 0 58
15. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma Watcharin Loilome
Sirinun Juntana
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Banchob Sripa
Masanao Miwa
Hideyuki Saya
Gregory J. Riggins
Puangrat Yongvanit
2011 INTERNATIONAL JOURNAL OF CANCER
1.0 (129.0), pp. 34.0-44.0
58 0 0 0 0 0 58
16. Anti-inflammatory Agents Suppress the Prostaglandin E-2 Production and Migration Ability of Cholangiocarcinoma Cell Lines Jurairat Jongthawin
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 47.0-51.0
17 0 0 0 0 0 17
17. Cytokines Released from Activated Human Macrophages Induce Epithelial Mesenchymal Transition Markers of Cholangiocarcinoma Cells Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Hasaya Dokduang
Jurairat Jongthawin
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 115.0-118.0
51 0 0 0 0 0 51
18. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Watcharin Loilome
Pairoj Wechagama
Nisana Namwat
Apinya Jusakul
Banchob Sripa
Masanao Miwa
Rahul Kuver
Puangrat Yongvanit
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 136.0-139.0
23 0 0 0 0 0 23
19. Expression Profiles of Oncomir miR-21 and Tumor Suppressor let-7a in the Progression of Opisthorchiasis-Associated Cholangiocarcinoma N. Namwat
P. Chusorn
W. Loilome
A. Techasen
J. Puetkasichonpasutha
C. Pairojkul
N. Khuntikeo
P. Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 65.0-69.0
25 0 0 0 0 0 25
20. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Puangrat Yongvanit
Emorn Phanomsri
Nisana Namwat
Jureeporn Kampan
Wichittra Tassaneeyakul
Watcharin Loilome
Anucha Puapairoj
Narong Khuntikeo
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 162.0-166.0
7 0 0 0 0 0 7
21. Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma Apinya Jusakul
Narong Khuntikeo
W. Geoffrey Haigh
Rahul Kuver
George N. Ioannou
Watcharin Loilome
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Ake Pugkhem
Chawalit Pairojkul
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 77.0-82.0
8 0 0 0 0 0 8
22. Identification of pathogenic cholesterol oxidation products in hepatic tissue and bile of cholangiocarcinoma patients A. Jusakul
W. G. Haigh
C. Savard
W. Loilome
N. Namwat
N. Khuntikeo
C. Pairojkul
S. Pinlaor
R. Kuver
P. Yongvanit
2012 FEBS JOURNAL
(279.0), pp. 216.0-216.0
0 0 0 0 0 0 0
23. Impaired Antioxidant Enzyme Activity and Increased DNA Repair Enzyme Expression in Hamster Liver Tissues Related to Cholangiocarcinoma Development Watcharin Loilome
Sasithorn Kadsanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Ananya Dechakhamphu
Chadamas Pinitsoontorn
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 59.0-64.0
3 0 0 0 0 0 3
24. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Puangrat Yongvanit
Raynoo Thanan
Somchai Pinlaor
Paiboon Sithithaworn
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Somkid Dechakhamphu
2012 PARASITOLOGY RESEARCH
5.0 (110.0), pp. 1969.0-1977.0
16 0 0 0 0 0 16
25. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Apinya Jusakul
Watcharin Loilome
Nisana Namwat
W. Geoffrey Haigh
Rahul Kuver
Somkid Dechakhamphu
Pradit Sukontawarin
Somchai Pinlaor
Sum P. Lee
Puangrat Yongvanit
2012 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
1-2 (731.0), pp. 48.0-57.0
34 0 0 0 0 0 34
26. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Kunyarat Duenngai
Ubon Cha'on
Raynoo Thanan
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 140.0-144.0
12 0 0 0 0 0 12
27. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Chariya Hahnvajanawong
Jariya Chaiyagool
Wunchana Seubwai
Vajarabhongsa Bhudhisawasdi
Nisana Namwat
Narong Khuntikeo
Banchob Sripa
Ake Pugkhem
Wichittra Tassaneeyakul
2012 WORLD JOURNAL OF GASTROENTEROLOGY
30.0 (18.0), pp. 3955.0-3961.0
20 0 0 0 0 0 20
28. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group Watcharin Loilome
Sasithorn Yooyuen
Nisana Namwat
Paiboon Sithithaworn
Anucha Puapairoj
Junko Kano
Masayuki Noguchi
Masanao Miwa
Puangrat Yongvanit
2012 TUMOR BIOLOGY
6.0 (33.0), pp. 2289.0-2298.0
10 0 0 0 0 0 10
29. Suppression of PRKAR1A Expression Enhances Antiproliferative and Apoptotic Effects of Protein Kinase Inhibitors and Chemotherapeutic Drugs on Cholangiocarcinoma Cells Watcharin Loilome
Sirinun Juntana
Chadamas Pinitsoontorn
Nisana Namwat
Wichittra Tassaneeyakul
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 143.0-147.0
3 0 0 0 0 0 3
30. Tumor Necrosis Factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma A. Techasen
N. Namwat
W. Loilome
2012 FEBS JOURNAL
(279.0), pp. 169.0-170.0
0 0 0 0 0 0 0
31. Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Pornpan Bungkanjana
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2012 MEDICAL ONCOLOGY
5.0 (29.0), pp. 3083.0-3091.0
74 0 0 0 0 0 74
32. Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Apinya Jusakul
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Rahul Kuver
George N. Ioannou
Christopher Savard
W. Geoffrey Haigh
Puangrat Yongvanit
2013 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
(138.0), pp. 368.0-375.0
14 0 0 0 0 0 14
33. Immunosuppressive Prednisolone Enhances Early Cholangiocarcinoma in Syrian Hamsters with Liver Fluke Infection and Administration of N-nitrosodimethylamine Amornrat Juasook
Thidarut Boonmars
Zhiliang Wu
Watcharin Loilome
Kulathida Veteewuthacharn
Nissana Namwat
Pakkayanee Sudsarn
Orasa Wonkchalee
Pranee Sriraj
Ratchadawan Aukkanimart
2013 PATHOLOGY & ONCOLOGY RESEARCH
1.0 (19.0), pp. 55.0-62.0
11 0 0 0 0 0 11
34. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Supak Yothaisong
Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Gregory J. Riggins
Watcharin Loilome
2013 TUMOR BIOLOGY
6.0 (34.0), pp. 3637.0-3648.0
73 0 0 0 0 0 73
35. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
A. Dechakhamphu
C. Talabnin
W. Chan-On
C. K. Ong
B. T. Teh
P. Yongvanit
2013 TUMOR BIOLOGY
3.0 (34.0), pp. 1579.0-1588.0
65 0 0 0 0 0 65
36. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Wassana Jamnongkan
Anchalee Techasen
Raynoo Thanan
Kunyarat Duenngai
Paiboon Sithithaworn
Eimorn Mairiang
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Puangrat Yongvanit
2013 TUMOR BIOLOGY
2.0 (34.0), pp. 695.0-704.0
23 0 0 0 0 0 23
37. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Hasaya Dokduang
Sirinun Juntana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Gregory J. Riggins
Watcharin Loilome
2013 TUMOR BIOLOGY
6.0 (34.0), pp. 3519.0-3528.0
36 0 0 0 0 0 36
38. The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma Jurairat Jongthawin
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Chavalit Pairojkul
Narong Khuntikeo
Nisana Namwat
2013 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(28.0), pp. 425.0-425.0
0 0 0 0 0 0 0
39. Activated macrophages promote Wnt/beta-catenin signaling in cholangiocarcinoma cells Watcharin Loilome
Pornpan Bungkanjana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Anucha Puapairoj
Narong Khuntikeo
Gregory J. Riggins
2014 TUMOR BIOLOGY
6.0 (35.0), pp. 5357.0-5367.0
60 0 0 0 0 0 60
40. Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
23.0 (15.0), pp. 10187.0-10192.0
12 0 0 0 0 0 12
41. BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma Kassaporn Duangkumpha
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Raynoo Thanan
Narong Khuntikeo
Puangrat Yongvanit
2014 TUMOR BIOLOGY
10.0 (35.0), pp. 9667.0-9676.0
49 0 0 0 0 0 49
42. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Porncheera Chusorn
Anchalee Techasen
Thidarut Boonmars
Narong Khuntikeo
Nittaya Chamadol
Chawalit Pairojkul
Nisana Namwat
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
12.0 (21.0), pp. 864.0-872.0
66 0 0 0 0 0 66
43. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
14.0 (15.0), pp. 5873.0-5878.0
37 0 0 0 0 0 37
44. Increased EphB2 expression predicts cholangiocarcinoma metastasis Walaiporn Khansaard
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Watcharin Loilome
2014 TUMOR BIOLOGY
10.0 (35.0), pp. 10031.0-10041.0
26 0 0 0 0 0 26
45. Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development H. Dokduang
W. Loilome
N. Namwat
C. Pairojkul
M. Sakurai-Yageta
Y. Murakami
P. Yongvanit
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S197-S197
0 0 0 0 0 0 0
46. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2014 TUMOR BIOLOGY
9.0 (35.0), pp. 8645.0-8652.0
43 0 0 0 0 0 43
47. Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/beta-catenin Signaling Pathways in a Cholangiocarcinogenesis Model Supak Yothaisong
Malinee Thanee
Nisana Namwat
Puangrat Yongvanit
Thidarut Boonmars
Anucha Puapairoj
Watcharin Loilome
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
23.0 (15.0), pp. 10463.0-10468.0
25 0 0 0 0 0 25
48. PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jurairat Jongthawin
Porncheera Chusorn
Anchalee Techasen
Watcharin Loilome
Thidarut Boonmars
Raynoo Thanan
Anucha Puapairoj
Narong Khuntikeo
Wichittra Tassaneeyakul
Puangrat Yongvanit
Nisana Namwat
2014 TUMOR BIOLOGY
8.0 (35.0), pp. 8051.0-8064.0
10 0 0 0 0 0 10
49. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Chawalit Pairojkul
Yoshinori Murakami
Watcharin Loilome
Puangrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
10.0 (21.0), pp. 767.0-776.0
52 0 0 0 0 0 52
50. Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment W. Loilome
H. Dokduang
S. Yothaisong
P. Bungkanjana
S. Juntana
A. Techasen
N. Namwat
P. Yongvanit
N. Khuntikeo
A. Puapairoj
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S210-S210
0 0 0 0 0 0 0
51. TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
B. Tean Teh
I. Lee
P. Yongvanit
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S63-S64
0 0 0 0 0 0 0
52. Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Kassaporn Duangkumpha
Anucha Puapairoj
Hideyuki Saya
Puangrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
9.0 (21.0), pp. 703.0-711.0
44 0 0 0 0 0 44
53. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine Chanika Worasith
Christine Kamamia
Anna Yakovleva
Kunyarat Duenngai
Chompunoot Wangboon
Jiraporn Sithithaworn
Nattaya Watwiengkam
Nisana Namwat
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Alex Loukas
Paiboon Sithithaworn
Jeffrey M. Bethony
2015 PLoS Neglected Tropical Diseases
10.0 (9.0), pp.
37 0 0 0 0 0 37
54. Cohort profile: cholangiocarcinoma screening and care program (CASCAP) Narong Khuntikeo
Nittaya Chamadol
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Paiboon Sithithaworn
Ross H. Andrews
Trevor N. Petney
Supannee Promthet
Kavin Thinkhamrop
Chaiwat Tawarungruang
Bandit Thinkhamrop
2015 BMC CANCER
(15.0), pp.
69 0 0 0 0 0 69
55. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wareeporn Wattanawongdon
Chariya Hahnvajanawong
Nisana Namwat
Sirimas Kanchanawat
Thidarut Boonmars
Patcharee Jearanaikoon
Chanwit Leelayuwat
Anchalee Techasen
Wunchana Seubwai
2015 INTERNATIONAL JOURNAL OF ONCOLOGY
1.0 (47.0), pp. 398.0-410.0
34 0 0 0 0 0 34
56. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Eiji Sugihara
Shogo Okazaki
Shinya Abe
Shiho Ueda
Takashi Masuko
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Chawalit Pairojkul
Hideyuki Saya
Puangrat Yongvanit
2016 CANCER SCIENCE
7.0 (107.0), pp. 991.0-1000.0
40 0 0 0 0 0 40
57. Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand Narong Khuntikeo
Paiboon Sithithaworn
Watcharin Loilom
Nisana Namwat
Puangrat Yongvanit
Bandit Thinkhamrop
Nadda Kiatsopit
Ross H. Andrews
Trevor N. Petney
2016 ACTA TROPICA
(164.0), pp. 469.0-472.0
16 0 0 0 0 0 16
58. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma Pakkayanee Sudsarn
Thidarut Boonmars
Wipaporn Ruangjirachuporn
Nisana Namwat
Watcharin Loilome
Pranee Sriraj
Ratchadawan Aukkanimart
Wonkchalee Nadchanan
Songsri Jiraporn
2016 PATHOLOGY & ONCOLOGY RESEARCH
1.0 (22.0), pp. 57.0-65.0
5 0 0 0 0 0 5
59. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Hasaya Dokduang
Watcharin Loilome
Narong Khuntikeo
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Anchalee Techasen
Nisana Namwat
2016 ANTICANCER RESEARCH
11.0 (36.0), pp. 5981.0-5988.0
12 0 0 0 0 0 12
60. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells Hasaya Dokduang
Puangrat Yongvanit
Nisana Namwat
Chawalit Pairojkul
Sakkarn Sangkhamanon
Mika Sakurai Yageta
Yoshinori Murakami
Watcharin Loilome
2016 ONCOLOGY REPORTS
4.0 (35.0), pp. 2065.0-2072.0
24 0 0 0 0 0 24
61. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Watcharin Loilome
Sasithorn Kadsanit
Kanha Muisook
Puangrat Yongvanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Narong Khuntikeo
Pichai Phonjit
2017 ONCOLOGY LETTERS
2.0 (13.0), pp. 639.0-646.0
5 0 0 0 0 0 5
62. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Supak Yothaisong
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Promsuk Jutabha
Naohiko Anzai
Wichittra Tassaneeyakul
Panot Tangsucharit
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 471.0-478.0
21 0 0 0 0 0 21
63. Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Supak Yothaisong
Hasaya Dokduang
Naohiko Anzai
Keitaro Hayashi
Nisana Namwat
Puangrat Yongvanit
Sakkarn Sangkhamanon
Promsuk Jutabha
Hitoshi Endou
Watcharin Loilome
2017 TUMOR BIOLOGY
3.0 (39.0), pp.
47 0 0 0 0 0 47
64. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017 ANTICANCER RESEARCH
7.0 (37.0), pp. 3591.0-3597.0
29 0 0 0 0 0 29
65. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem Thomas Hughes
Thomas O'Connor
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Ross H. Andrews-
Narong Khuntikeo
Puangrat Yongvanit
Paiboon Sithithaworn
Simon D. Taylor-Robinson
2017 INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(10.0), pp. 227.0-237.0
54 0 0 0 0 0 54
66. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Manida Suksawat
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Supinda Koonmee
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 486.0-493.0
13 0 0 0 0 0 13
67. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017 ONCOLOGY LETTERS
5.0 (14.0), pp. 5973.0-5979.0
15 0 0 0 0 0 15
68. Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool Wassana Jamnongkan
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Piyapharom Intarawichian
Attapol Titapun
Puangrat Yongvanit
2017 TUMOR BIOLOGY
7.0 (39.0), pp.
23 0 0 0 0 0 23
69. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Suyanee Thongchot
Paiboon Sithithaworn
Thidarut Boonmars
Supinda Koonmee
Attapol Titapun
Narong Khuntikeo
Nittaya Chamadol
Anchalee Techasen
Nisana Namwat
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 479.0-485.0
39 0 0 0 0 0 39
70. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Rayno Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
Anchalee Techasen
2018 PEERJ
(6.0), pp.
12 0 0 0 0 0 12
71. CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Nisana Namwat
Attapon Titapun
Narong Khuntikeo
Shogo Okazaki
Eiji Sugihara
Hideyuki Saya
Puangrat Yongvanit
2018 CANCER SCIENCE
(109.0), pp. 37.0-37.0
0 0 0 0 0 0 0
72. Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma Chayanit Piyawajanusorn
Watcharin Loilome
Yingpinyapat Kittirat
Suyanee Thongchot
Nisana Namwat
2018 CANCER SCIENCE
(109.0), pp. 1382.0-1382.0
0 0 0 0 0 0 0
73. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway Suyanee Thongchot
Chiara Vidoni
Alessandra Ferraresi
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018 MOLECULAR CARCINOGENESIS
12.0 (57.0), pp. 1735.0-1750.0
46 0 0 0 0 0 46
74. Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis Anchalee Techasen
Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
2018 CANCER SCIENCE
(109.0), pp. 721.0-721.0
0 0 0 0 0 0 0
75. Expressions of FOXAs in relation with good prognosis of cholangiocarcinoma Waleeporn Kaewlert
Napat Armartmuntree
Nisana Namwat
Kanlayanee Sawanyawisuth
Chadamas Sakonsinsiri
Raynoo Thanan
2018 CANCER SCIENCE
(109.0), pp. 1137.0-1137.0
0 0 0 0 0 0 0
76. Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development Sasikamon Korphai
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 194.0-194.0
0 0 0 0 0 0 0
77. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy Manida Suksawat
Anchalee Techasen
Nisana Namwat
Thianrut Boonsong
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Watcharin Loilome
2018 FEBS OPEN BIO
4.0 (8.0), pp. 513.0-522.0
7 0 0 0 0 0 7
78. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 746.0-746.0
0 0 0 0 0 0 0
79. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 ONCOLOGY LETTERS
2.0 (16.0), pp. 1627.0-1633.0
14 0 0 0 0 0 14
80. Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018 CANCER SCIENCE
(109.0), pp. 1286.0-1286.0
0 0 0 0 0 0 0
81. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 745.0-745.0
0 0 0 0 0 0 0
82. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Runglawan Silakit
Yingpinyapat Kitirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Piti Ungarreevittaya
Narong Khuntikeo
Puangrat Yongvanit
Ji Hye Yang
Nam Hee Kim
Jong In Yook
Nisana Namwat
2018 PLOS ONE
6.0 (13.0), pp.
18 0 0 0 0 0 18
83. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Minerva Daya
Watcharin Loilome
Anchalee Techasen
Malinee Thanee
Prakasit Sa-Ngiamwibool
Attapol Titapun
Puangrat Yongvanit
Nisana Namwat
2018 ONCOTARGETS AND THERAPY
(11.0), pp. 395.0-408.0
18 0 0 0 0 0 18
84. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018 REDOX BIOLOGY
(14.0), pp. 637.0-644.0
115 0 0 0 0 0 115
85. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells Suyanee Thongchot
Alessandra Ferraresi
Chiara Vidoni
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018 CANCER LETTERS
(430.0), pp. 160.0-171.0
51 0 0 0 0 0 51
86. Resveratrol interrupts the pro -invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells (vol 430C, pg 160, 2018) Suyanee Thongchot
Alessandra Ferraresi
Chiara Vidoni
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018 CANCER LETTERS
(434.0), pp. 206.0-207.0
7 0 0 0 0 0 7
87. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018 ONCOLOGY LETTERS
1.0 (15.0), pp. 347.0-353.0
9 0 0 0 0 0 9
88. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018 CANCER SCIENCE
(109.0), pp. 956.0-956.0
0 0 0 0 0 0 0
89. The importance of aromatase, an estrogen biosynthesis enzyme, in cholangiocarcinoma progression Raynoo Thanan
Waleeporn Kaewlert
Napat Armartmuntree
Chadamas Sakonsinsiri
Nisana Namwat
Kanlayanee Sawanyawisuth
Piti Ungarreevittaya
2018 CANCER SCIENCE
(109.0), pp. 721.0-721.0
0 0 0 0 0 0 0
90. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma Waleeporn Kaewlert
Chadamas Sakonsinsiri
Nisana Namwat
Kanlayanee Sawanyawisuth
Piti Ungarreevittaya
Narong Khuntikeo
Napat Armartmuntree
Raynoo Thanan
2018 HORMONES & CANCER
6.0 (9.0), pp. 408.0-419.0
10 0 0 0 0 0 10
91. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway Sasikamon Khophai
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Poramate Klanrit
Attapol Titapun
Apiwat Jarearnrat
Prakasit Sa-Ngiamwibool
Watcharin Loilome
2018 ONCOTARGETS AND THERAPY
(11.0), pp. 7019.0-7029.0
9 0 0 0 0 0 9
92. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Chanika Worasith
Chompunoot Wangboon
Kunyarat Duenngai
Nadda Kiatsopit
Kulthida Kopolrat
Anchalee Techasen
Jiraporn Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Nisana Namwat
Puangrat Yongvanit
Elizabeth J. Carlton
Paiboon Sithithaworn
2019 PLOS NEGLECTED TROPICAL DISEASES
2.0 (13.0), pp.
7 0 0 0 0 0 7
93. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019 JOURNAL OF PROTEOME RESEARCH
9.0 (18.0), pp. 3305.0-3316.0
12 0 0 0 0 0 12
94. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Bundit Promraksa
Jutarop Phetcharaburanin
Nisana Namwat
Anchalee Techasen
Patcharee Boonsiri
Watcharin Loilome
2019 PLOS ONE
5.0 (14.0), pp.
7 0 0 0 0 0 7
95. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Manida Suksawat
Poramate Klanrit
Jutarop Phetcharaburanin
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Apiwat Jarearnrat
Prakasit Sa-ngiamwibool
Anchalee Techasen
Watcharin Loilome
2019 PLOS ONE
9.0 (14.0), pp.
5 0 0 0 0 0 5
96. PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells Chayanit Piyawajanusorn
Yingpinyapat Kittirat
Prakasit Sa-Ngiamwibool
Attapol Titapun
Watcharin Loilome
Nisana Namwat
2019 CANCER GENOMICS & PROTEOMICS
6.0 (16.0), pp. 543.0-552.0
0 0 0 0 0 0 0
97. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress Timpika Chaiprasert
Napat Armartmuntree
Anchalee Techasen
Chadamas Sakonsinsiri
Somchai Pinlaor
Piti Ungarreevittaya
Narong Khuntikeo
Nisana Namwat
Raynoo Thanan
2019 BIOMOLECULES
7.0 (9.0), pp.
4 0 0 0 0 0 4
98. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019 PLOS ONE
8.0 (14.0), pp.
16 0 0 0 0 0 16
99. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients Narong Khuntikeo
Supinda Koonmee
Prakasit Sa-Ngiamwibool
Nittaya Chamadol
Vallop Laopaiboon
Attapol Titapun
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Ross H. Andrews
Trevor N. Petney
Kavin Thinkhamrop
Nathaphop Chaichaya
Chaiwat Tawarungruang
Jaruwan Thuanman
Bandit Thinkhamrop
2020 HPB
6.0 (22.0), pp. 874.0-883.0
1 0 0 0 0 0 1
100. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma Sureerat Padthaisong
Malinee Thanee
Nisana Namwat
Jutarop Phetcharaburanin
Poramate Klanrit
Narong Khuntikeo
Attapol Titapun
Watcharin Loilome
2020 BMC CANCER
1.0 (20.0), pp.
4 0 0 0 0 0 4
101. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Wichit Taron
Wassana Jamnongkan
Anchalee Techasen
Jutarop Phetcharaburanin
Nisana Namwat
Paiboon Sithithaworn
Narong Khuntikeo
Siriboon Mukdasai
Somphou Sayasone
Watcharin Loilome
Wittaya Ngeontae
2020 TALANTA
(209.0), pp.
5 0 0 0 0 0 5
102. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Suyanee Thongchot
Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Thidarat Boonmars
Prakasit Sa-Ngiamwibool
Attapol Titapun
Puangrat Yongvanit
Ciro Isidoro
Nisana Namwat
2020 JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE
3.0 (10.0), pp. 230.0-235.0
3 0 0 0 0 0 3
103. H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination Jutarop Phetcharaburanin
Suthicha Deewai
Thanaporn Kulthawatsiri
Komkid Moolpia
Manida Suksawat
Bundit Promraksa
Poramate Klanrit
Nisana Namwat
Watcharin Loilome
Kitisak Poopasit
Somporn Katekaew
Penprapa Phetcharaburanin
2020 PLOS ONE
12.0 (15.0), pp.
0 0 0 0 0 0 0
104. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines Hasaya Dokduang
Wassana Jamnongkarn
Bundit Promraksa
Manida Suksawat
Sureerat Padthaisong
Malinee Thanee
Jutarop Phetcharaburanin
Nisana Namwat
Sakkarn Sangkhamanon
Attapol Titapun
Narong Khuntikeo
Poramate Klanrit
Watcharin Loilome
2020 DRUG DESIGN DEVELOPMENT AND THERAPY
(14.0), pp. 2319.0-2334.0
2 0 0 0 0 0 2
105. LIVER FLUKE-INFECTED CYPRINOID FISH IN NORTHEASTERN THAILAND (2016-2017) Benjamabhorn Pumhirunroj
Ratchadawan Aukkanimart
Thidarut Boonmars
Pranee Sriraj
Parichart Boueroy
Atchara Artchayasawat
Jiraporn Songsri
Panupan Sripan
Kanpicha Chomphumee
Panaratana Ratanasuwan
Porntip Laummaunwai
Sukhonthip Khueangchaingkhwang
Apiporn Suwanatri
Surasit Aunpromma
Chatanun Eamudomkarn
Narong Khuntikeo
Watcharin Loilome
Nisana Namwat
Puangrat Yongvanit
2020 SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH
1.0 (51.0), pp. 1.0-7.0
0 0 0 0 0 0 0
106. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Sureerat Padthaisong
Malinee Thanee
Nisana Namwat
Jutarop Phetcharaburanin
Poramate Klanrit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sungkhamanon
Hideyuki Saya
Watcharin Loilome
2020 JOURNAL OF TRANSLATIONAL MEDICINE
1.0 (18.0), pp.
0 0 0 0 0 0 0
107. A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples Wichit Taron
Wassana Jamnongkan
Jutarop Phetcharaburanin
Poramate Klanrit
Nisana Namwat
Anchalee Techasen
Paiboon Sithithaworn
Narong Khuntikeo
Thidarut Boonmars
Watcharin Loilome
Wittaya Ngeontae
2021 SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
(254.0), pp.
2 0 0 0 0 0 2
108. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway Sutthiwan Janthamala
Apinya Jusakul
Sarinya Kongpetch
Phongsaran Kimawaha
Poramate Klanrit
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
2021 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
10.0 (394.0), pp. 2049.0-2059.0
0 0 0 0 0 0 0
109. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits Phuc N. Ho
Poramate Klanrit
Yupa Hanboonsong
Umaporn Yordpratum
Manida Suksawat
Thanaporn Kulthawatsiri
Anyarin Jirahiranpat
Suthicha Deewai
Panya Mackawan
Rasana W. Sermswan
Nisana Namwat
Watcharin Loilome
Tueanjit Khampitak
Arporn Wangwiwatsin
Jutarop Phetcharaburanin
2021 SCIENTIFIC REPORTS
1.0 (11.0), pp.
0 0 0 0 0 0 0
110. Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse Suyanee Thongchot
Chiara Vidoni
Alessandra Ferraresi
Watcharin Loilome
Narong Khuntikeo
Sakkarn Sangkhamanon
Attapol Titapun
Ciro Isidoro
Nisana Namwat
2021 CANCERS
9.0 (13.0), pp.
4 0 0 0 0 0 4
111. CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression Malinee Thanee
Hasaya Dokduang
Yingpinyapat Kittirat
Jutarop Phetcharaburanin
Poramate Klanrit
Attapol Titapun
Nisana Namwat
Narong Khuntikeo
Arporn Wangwiwatsin
Hideyuki Saya
Watcharin Loilome
2021 PLOS ONE
3.0 (16.0), pp.
0 0 0 0 0 0 0
112. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma Preawwalee Wintachai
Jing Quan Lim
Anchalee Techasen
Worachart Lert-Itthiporn
Sarinya Kongpetch
Watcharin Loilome
Jarin Chindaprasirt
Attapol Titapun
Nisana Namwat
Narong Khuntikeo
Apinya Jusakul
2021 DIAGNOSTICS
6.0 (11.0), pp.
0 0 0 0 0 0 0
113. Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma Sureerat Padthaisong
Jutarop Phetcharaburanin
Poramate Klanrit
Jia Li
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Apiwat Jarearnrat
Arporn Wangwiwatsin
Panupong Mahalapbutr
Watcharin Loilome
2021 CANCER & METABOLISM
1.0 (9.0), pp.
1 0 0 0 0 0 1
114. Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction Yingpinyapat Kittirat
Jutarop Phetcharaburanin
Bundit Promraksa
Thanaporn Kulthawatsiri
Arporn Wangwiwatsin
Poramate Klanrit
Sakkarn Sangkhamanon
Apiwat Jarearnrat
Suyanee Thongchot
Panupong Mahalapbutr
Watcharin Loilome
Hideyuki Saya
Nisana Namwat
2021 FRONTIERS IN PUBLIC HEALTH
(9.0), pp.
0 0 0 0 0 0 0
115. Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment Bundit Promraksa
Praewpan Katrun
Jutarop Phetcharaburanin
Yingpinyapat Kittirat
Nisana Namwat
Anchalee Techasen
Jia V. Li
Watcharin Loilome
2021 BIOMOLECULES
3.0 (11.0), pp.
0 0 0 0 0 0 0
116. Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma Pattama Prommajun
Jutarop Phetcharaburanin
Nisana Namwat
Poramate Klanrit
Prakasit Sa-Ngiamwibool
Malinee Thanee
Hasaya Dokduang
Yingpinyapat Kittirat
Jia Li
Watcharin Loilome
2021 CANCER GENOMICS & PROTEOMICS
1.0 (18.0), pp. 29.0-42.0
0 0 0 0 0 0 0
117. Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples Wichit Taron
Kittirat Phooplub
Sasina Sanchimplee
Kanitpong Piyanamvanich
Wassana Jamnongkan
Anchalee Techasen
Jutarop Phetcharaburanin
Poramate Klanrit
Nisana Namwat
Narong Khuntikeo
Thidarut Boonmars
Paiboon Sithithaworn
Sirirat Ouiganon
Proespichaya Kanatharana
Panote Thavarungkul
Chittanon Buranachai
Watcharin Loilome
Wittaya Ngeontae
2021 SENSORS AND ACTUATORS B-CHEMICAL
(348.0), pp.
0 0 0 0 0 0 0
118. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models Malinee Thanee
Sureerat Padthaisong
Manida Suksawat
Hasaya Dokduang
Jutarop Phetcharaburanin
Poramate Klanrit
Attapol Titapun
Nisana Namwat
Arporn Wangwiwatsin
Prakasit Sa-ngiamwibool
Narong Khuntikeo
Hideyuki Saya
Watcharin Loilome
2021 CANCER & METABOLISM
1.0 (9.0), pp.
2 0 0 0 0 0 2
119. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression Jittima Tomacha
Hasaya Dokduang
Sureerat Padthaisong
Nisana Namwat
Poramate Klanrit
Jutarop Phetcharaburanin
Arporn Wangwiwatsin
Tueanjit Khampitak
Supinda Koonmee
Attapol Titapun
Apiwat Jarearnrat
Narong Khuntikeo
Watcharin Loilome
2021 FRONTIERS IN PHARMACOLOGY
(12.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title
1. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines Nisana Namwat
Banchob Sripa
Watcharin Loilome
Vajarabhongsa Bhudisawadi
Wichittra Tassaneeyakul
2007 Srinagarind Medical Journal
(22 No 3), pp. 230-234
2. Comparison of Antigen Retrieval Techniques in Immunohistochemistry Em-orn Phanomsri
Nisana Namwat
Sakda Waraasawapati
Roongpet Tangrassameeprasert
Supinda Koonmee
2009 Srinagarind Medical Journal
(24 No 2), pp. 130-136
3. Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation Hasaya Dokduang
Nisana Namwat
Apinya Jusakul
Vajarabhongsa Bhudisawadi
Watcharin Loilome
Puangrat Yongvanit
Banchob Sripa
Wichittra Tassaneeyakul
2010 Srinagarind Medical Journal
(25 No 1), pp. 2-5
4. Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines Chariya Hahnvajanawong
Vajarabhongsa Bhudisawadi
Nisana Namwat
Banchob Sripa
Wichittra Tassaneeyakul
2011 Srinagarind Medical Journal
(26 No 1), pp. 2-8
5. Plama MicroRNAs: a Biomarker for Cancer Diagnosis Runglawan Silakit
Nisana Namwat
2012 Srinagarind Medical Journal
(27 No 3), pp. 310-316
6. Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma Nisana Namwat
Watcharin Loilome
Puangrat Yongvanit
Thailand Khon Kaen University
2012 Srinagarind Medical Journal
(27), pp. 364-370
7. Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model Hasaya Dokduang
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Chawalit Pairojkul
Narong Khuntikeo
Yoshinori Murakami
Puangrat Yongvanit
2013 Srinagarind Medical Journal
(28 No 4), pp. 195
8. Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression Yingpinyapat Kittirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 133-135
9. Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 138-140
10. Gene Silencing of Translationally Controlled Tumor Protein (TCTP) Nattaporn Phanthaphol
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 136-137

Title Authors NRIIS type Year NRIIS Scholarship
1. ตัวตรวจชีวภาพในการคัดกรองกลุ่มเสี่ยงต่อโรคมะเร็งท่อน้ำดีที่สัมพันธ์กับการติดเชื้อพยาธิใบไม้ตับ รศ.ดร. นิษณา นามวาท
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ศ.ดร. พวงรัตน์ ยงวณิชย์
ศ.ดร. สมชาย ปิ่นละออ
รศ.ดร. วัชรินทร์ ลอยลม
ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
2. แบบแผนเปบทีโดมิกส์ในปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อัญชลี เตชะเสน
ดร. สิทธิรักษ์ รอยตระกูล
รศ.ดร.นพ. ณรงค์ ขันตีแก้ว
รศ.ดร. นิษณา นามวาท
ศ.ดร. ไพบูลย์ สิทธิถาวร
ศ.ดร. พวงรัตน์ ยงวณิชย์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
3. แบบแผนโปรทิโอมิกส์ในซีรัมของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง ศ.ดร. พวงรัตน์ ยงวณิชย์
อ.ดร. อัญชลี เตชะเสน
ดร. สิทธิรักษ์ รอยตระกูล
รศ.ดร.นพ. ณรงค์ ขันตีแก้ว
รศ.ดร. นิษณา นามวาท
ศ.ดร. ไพบูลย์ สิทธิถาวร
รศ.ดร. วัชรินทร์ ลอยลม
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
4. แบบแผนไมโครอาร์เอ็นเอในซีรัมและปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยงของโรคมะเร็งท่อน้ำดี รศ.ดร. นิษณา นามวาท
ศ.ดร. ไพบูลย์ สิทธิถาวร
นายชวลิต ไพโรจน์กุล
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อัญชลี เตชะเสน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
5. การวิเคราะห์ลักษณะของเซลล์มะเร็งท่อน้ำดี ที่ดื้อต่อยา gemcitabine และการทำให้เซลล์ที่ดื้อต่อยา gemcitabine กลับไปไวต่อยาโดยใช้ caged xanthones และ rhinacanthin-C ผศ.ดร. ศิริมาศ กาญจนวาศ
นางจริยา หาญวจนวงศ์
ศ.ดร. วิจิตรา ทัศนียกุล
รศ.ดร. นิษณา นามวาท
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร.นพ. สุวิน ว่องวัจนะ
ศ.ดร. วิชัย ริ้วตระกูล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2558 ทุนงบประมาณแผ่นดินประจำปี 2558
6. กลไกการเปลี่ยนแปลงรูปร่างของเซลล์จากเยื่อบุผิวเป็นมีเซนไคม์ในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา อ.ดร. อัญชลี เตชะเสน
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. วัชรินทร์ ลอยลม
รศ.ดร. นิษณา นามวาท
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ผศ.ดร. เรณู ทานันท์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
7. การควบคุมวิถีออโตฟาจีในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา รศ.ดร. นิษณา นามวาท
รศ.ดร. วัชรินทร์ ลอยลม
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ศ.ดร. พวงรัตน์ ยงวณิชย์
ผศ.ดร. เรณู ทานันท์
อ.ดร. อัญชลี เตชะเสน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
8. บทบาทของยีนก่อมะเร็งท่อน้ำดีในสภาวะความเครียดออกซิเดชันที่สัมพันธ์กับกระบวนการเหนือพันธุกรรมเพื่อการป้องกันและรักษาโรค ผศ.ดร. เรณู ทานันท์
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. วัชรินทร์ ลอยลม
ศ.ดร. สมชาย ปิ่นละออ
อ.ดร. อัญชลี เตชะเสน
รศ.ดร. นิษณา นามวาท
นายชวลิต ไพโรจน์กุล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
9. ยีนก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับโรคพยาธิใบไม้ตับ: เป้าหมายใหม่สำหรับการป้องกันและรักษา รศ.ดร. นิษณา นามวาท
ผศ.ดร. เรณู ทานันท์
รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อัญชลี เตชะเสน
ศ.ดร. สมชาย ปิ่นละออ
ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
10. ฤทธิ์ของสารยั้บยั้งวิถีการส่งสัญญาณของโปรตีนไคเนสเพื่อใช้ในการป้องกันและรักษาโรคมะเร็งท่อน้ำดี รศ.ดร. วัชรินทร์ ลอยลม
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. นิษณา นามวาท
อ.ดร. อัญชลี เตชะเสน
ผศ.ดร. เรณู ทานันท์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
11. การประยุกต์ใช้เทคนิค histoculture drug response assays ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี รศ.ดร. วัชรินทร์ ลอยลม
รศ.ดร. นิษณา นามวาท
อ.ดร. อัญชลี เตชะเสน
อ.ดร. อภิญญา จุ๊สกุล
นพ. อรรถพล ติตะปัญ
ม.ล. มานิดา ศุขสวัสดิ
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)
12. การพัฒนาชุดตรวจทางชีวภาพเพื่อใช้ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อภิญญา จุ๊สกุล
รศ.ดร. นิษณา นามวาท
อ.ดร. อัญชลี เตชะเสน
ชุดโครงการวิจัย 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)

0.058794260025024414